The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Abstract Background Despite preventive efforts, influenza epidemics are responsible for substantial morbidity and mortality every year in the United States (US). Vaccination strategies to reduce disease burden have been implemented. However, no previous studies have systematically estimated the annu...
Saved in:
| Published in | Vaccine Vol. 25; no. 27; pp. 5086 - 5096 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford
Elsevier Ltd
28.06.2007
Elsevier Elsevier Limited |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Abstract Background Despite preventive efforts, influenza epidemics are responsible for substantial morbidity and mortality every year in the United States (US). Vaccination strategies to reduce disease burden have been implemented. However, no previous studies have systematically estimated the annual economic burden of influenza epidemics, an estimate necessary to guide policy makers effectively. Objective We estimate age- and risk-specific disease burden, and medical and indirect costs attributable to annual influenza epidemics in the United States. Methods Using a probabilistic model and publicly available epidemiological data we estimated the number of influenza-attributable cases leading to outpatient visits, hospitalization, and mortality, as well as time lost from work absenteeism or premature death. With data from health insurance claims and projections of either earnings or statistical life values, we then estimated healthcare resource utilization associated with influenza cases as were their medical and productivity (indirect) costs in $2003. Results Based on 2003 US population, we estimated that annual influenza epidemics resulted in an average of 610,660 life-years lost (undiscounted), 3.1 million hospitalized days, and 31.4 million outpatient visits. Direct medical costs averaged $10.4 billion (95% confidence interval [C.I.], $4.1, $22.2) annually. Projected lost earnings due to illness and loss of life amounted to $16.3 billion (C.I., $8.7, $31.0) annually. The total economic burden of annual influenza epidemics using projected statistical life values amounted to $87.1 billion (C.I., $47.2, $149.5). Conclusions These results highlight the enormous annual burden of influenza in the US. While hospitalization costs are important contributors, lost productivity from missed work days and lost lives comprise the bulk of the economic burden of influenza. |
|---|---|
| AbstractList | Background Despite preventive efforts, influenza epidemics are responsible for substantial morbidity and mortality every year in the United States (US). Vaccination strategies to reduce disease burden have been implemented. However, no previous studies have systematically estimated the annual economic burden of influenza epidemics, an estimate necessary to guide policy makers effectively. Objective We estimate age- and risk-specific disease burden, and medical and indirect costs attributable to annual influenza epidemics in the United States. Methods Using a probabilistic model and publicly available epidemiological data we estimated the number of influenza-attributable cases leading to outpatient visits, hospitalization, and mortality, as well as time lost from work absenteeism or premature death. With data from health insurance claims and projections of either earnings or statistical life values, we then estimated healthcare resource utilization associated with influenza cases as were their medical and productivity (indirect) costs in $2003. Results Based on 2003 US population, we estimated that annual influenza epidemics resulted in an average of 610,660 life-years lost (undiscounted), 3.1million hospitalized days, and 31.4million outpatient visits. Direct medical costs averaged $10.4billion (95% confidence interval [C.I.], $4.1, $22.2) annually. Projected lost earnings due to illness and loss of life amounted to $16.3billion (C.I., $8.7, $31.0) annually. The total economic burden of annual influenza epidemics using projected statistical life values amounted to $87.1billion (C.I., $47.2, $149.5). Conclusions These results highlight the enormous annual burden of influenza in the US. While hospitalization costs are important contributors, lost productivity from missed work days and lost lives comprise the bulk of the economic burden of influenza. Despite preventive efforts, influenza epidemics are responsible for substantial morbidity and mortality every year in the United States (US). Vaccination strategies to reduce disease burden have been implemented. However, no previous studies have systematically estimated the annual economic burden of influenza epidemics, an estimate necessary to guide policy makers effectively. We estimate age- and risk-specific disease burden, and medical and indirect costs attributable to annual influenza epidemics in the United States. Using a probabilistic model and publicly available epidemiological data we estimated the number of influenza-attributable cases leading to outpatient visits, hospitalization, and mortality, as well as time lost from work absenteeism or premature death. With data from health insurance claims and projections of either earnings or statistical life values, we then estimated healthcare resource utilization associated with influenza cases as were their medical and productivity (indirect) costs in $2003. Based on 2003 US population, we estimated that annual influenza epidemics resulted in an average of 610,660 life-years lost (undiscounted), 3.1 million hospitalized days, and 31.4 million outpatient visits. Direct medical costs averaged $10.4 billion (95% confidence interval [C.I.], $4.1, $22.2) annually. Projected lost earnings due to illness and loss of life amounted to $16.3 billion (C.I., $8.7, $31.0) annually. The total economic burden of annual influenza epidemics using projected statistical life values amounted to $87.1 billion (C.I., $47.2, $149.5). These results highlight the enormous annual burden of influenza in the US. While hospitalization costs are important contributors, lost productivity from missed work days and lost lives comprise the bulk of the economic burden of influenza. Abstract Background Despite preventive efforts, influenza epidemics are responsible for substantial morbidity and mortality every year in the United States (US). Vaccination strategies to reduce disease burden have been implemented. However, no previous studies have systematically estimated the annual economic burden of influenza epidemics, an estimate necessary to guide policy makers effectively. Objective We estimate age- and risk-specific disease burden, and medical and indirect costs attributable to annual influenza epidemics in the United States. Methods Using a probabilistic model and publicly available epidemiological data we estimated the number of influenza-attributable cases leading to outpatient visits, hospitalization, and mortality, as well as time lost from work absenteeism or premature death. With data from health insurance claims and projections of either earnings or statistical life values, we then estimated healthcare resource utilization associated with influenza cases as were their medical and productivity (indirect) costs in $2003. Results Based on 2003 US population, we estimated that annual influenza epidemics resulted in an average of 610,660 life-years lost (undiscounted), 3.1 million hospitalized days, and 31.4 million outpatient visits. Direct medical costs averaged $10.4 billion (95% confidence interval [C.I.], $4.1, $22.2) annually. Projected lost earnings due to illness and loss of life amounted to $16.3 billion (C.I., $8.7, $31.0) annually. The total economic burden of annual influenza epidemics using projected statistical life values amounted to $87.1 billion (C.I., $47.2, $149.5). Conclusions These results highlight the enormous annual burden of influenza in the US. While hospitalization costs are important contributors, lost productivity from missed work days and lost lives comprise the bulk of the economic burden of influenza. BACKGROUNDDespite preventive efforts, influenza epidemics are responsible for substantial morbidity and mortality every year in the United States (US). Vaccination strategies to reduce disease burden have been implemented. However, no previous studies have systematically estimated the annual economic burden of influenza epidemics, an estimate necessary to guide policy makers effectively.OBJECTIVEWe estimate age- and risk-specific disease burden, and medical and indirect costs attributable to annual influenza epidemics in the United States.METHODSUsing a probabilistic model and publicly available epidemiological data we estimated the number of influenza-attributable cases leading to outpatient visits, hospitalization, and mortality, as well as time lost from work absenteeism or premature death. With data from health insurance claims and projections of either earnings or statistical life values, we then estimated healthcare resource utilization associated with influenza cases as were their medical and productivity (indirect) costs in $2003.RESULTSBased on 2003 US population, we estimated that annual influenza epidemics resulted in an average of 610,660 life-years lost (undiscounted), 3.1 million hospitalized days, and 31.4 million outpatient visits. Direct medical costs averaged $10.4 billion (95% confidence interval [C.I.], $4.1, $22.2) annually. Projected lost earnings due to illness and loss of life amounted to $16.3 billion (C.I., $8.7, $31.0) annually. The total economic burden of annual influenza epidemics using projected statistical life values amounted to $87.1 billion (C.I., $47.2, $149.5).CONCLUSIONSThese results highlight the enormous annual burden of influenza in the US. While hospitalization costs are important contributors, lost productivity from missed work days and lost lives comprise the bulk of the economic burden of influenza. Despite preventive efforts, influenza epidemics are responsible for substantial morbidity and mortality every year in the United States (US). Vaccination strategies to reduce disease burden have been implemented. However, no previous studies have systematically estimated the annual economic burden of influenza epidemics, an estimate necessary to guide policy makers effectively. We estimate age- and risk-specific disease burden, and medical and indirect costs attributable to annual influenza epidemics in the United States. Using a probabilistic model and publicly available epidemiological data we estimated the number of influenza-attributable cases leading to outpatient visits, hospitalization, and mortality, as well as time lost from work absenteeism or premature death. With data from health insurance claims and projections of either earnings or statistical life values, we then estimated healthcare resource utilization associated with influenza cases as were their medical and productivity (indirect) costs in $2003. Based on 2003 US population, we estimated that annual influenza epidemics resulted in an average of 610,660 life-years lost (undiscounted), 3.1 million hospitalized days, and 31.4 million outpatient visits. Direct medical costs averaged $10.4 billion (95% confidence interval [C.I.], $4.1, $22.2) annually. Projected lost earnings due to illness and loss of life amounted to $16.3 billion (C.I., $8.7, $31.0) annually. The total economic burden of annual influenza epidemics using projected statistical life values amounted to $87.1 billion (C.I., $47.2, $149.5). These results highlight the enormous annual burden of influenza in the US. While hospitalization costs are important contributors, lost productivity from missed work days and lost lives comprise the bulk of the economic burden of influenza. |
| Author | Wortley, Pascale M Bridges, Carolyn B Weintraub, Eric Molinari, Noelle-Angelique M Ortega-Sanchez, Ismael R Messonnier, Mark L Thompson, William W |
| Author_xml | – sequence: 1 fullname: Molinari, Noelle-Angelique M – sequence: 2 fullname: Ortega-Sanchez, Ismael R – sequence: 3 fullname: Messonnier, Mark L – sequence: 4 fullname: Thompson, William W – sequence: 5 fullname: Wortley, Pascale M – sequence: 6 fullname: Weintraub, Eric – sequence: 7 fullname: Bridges, Carolyn B |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18846567$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17544181$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkl1rFDEUhoNU7Lb6E5QBsXeznnxnvFCk1A-oeNEueBeymTOadTazTWYK9debYRcWetOrhJPnvEne95yRkzhEJOQ1hSUFqt5vlvfO-xBxyQD0EvgShHpGFtRoXjNJzQlZAFOiFhR-nZKznDcAIDltXpBTqqUQ1NAFWd3-wcrFOLm-Ctud82M1dFVGl4c4l2LXTxj_ubKrxoKubj5UP8rplEL8XbVhJrFaT6nFWHTayg95zC_J8871GV8d1nOy-nJ1e_mtvv759fvl5-vaKwZjrbqWcUW1QCqY8OANFa1WErQDpxtcU2ClBkYyZ0ShZSMapYTxumlavubn5GKvu0vD3YR5tNuQPfa9izhM2WpQ1DDJnwQZcNDcyAK-fQRuhikVK7KlUjZghOCiUHJP-TTknLCzuxS2Lj1YCnaOx27sIR47x2OB2xJP6XtzUJ_WW2yPXYc8CvDuALjsXd8lF33IR84UG6TShfu057C4ex8w2ewDRo9tSOhH2w7hyad8fKTg-xBDufQvPmA-_tpmZsHezLM0jxJogGKU4P8BetDEGA |
| CODEN | VACCDE |
| CitedBy_id | crossref_primary_10_1016_j_vaccine_2019_10_019 crossref_primary_10_2165_11597310_000000000_00000 crossref_primary_10_2139_ssrn_3098854 crossref_primary_10_24911_IJMDC_51_1607762689 crossref_primary_10_1097_MOP_0b013e32832185af crossref_primary_10_1016_j_medj_2020_06_008 crossref_primary_10_1016_j_hermed_2023_100743 crossref_primary_10_1080_21645515_2017_1388480 crossref_primary_10_35516_jjps_v16i4_607 crossref_primary_10_1186_1471_2334_14_133 crossref_primary_10_1128_AAC_01739_09 crossref_primary_10_1016_j_jinf_2015_07_008 crossref_primary_10_3389_fevo_2019_00036 crossref_primary_10_3390_diagnostics11030462 crossref_primary_10_1097_JOM_0000000000001120 crossref_primary_10_1016_j_japh_2020_04_023 crossref_primary_10_1371_journal_pone_0146620 crossref_primary_10_1377_hlthaff_2020_00426 crossref_primary_10_1177_1403494811402720 crossref_primary_10_1186_s12889_022_12505_5 crossref_primary_10_1371_journal_pone_0166232 crossref_primary_10_1016_j_arr_2015_07_005 crossref_primary_10_1016_j_infect_2015_04_002 crossref_primary_10_1371_journal_pone_0098446 crossref_primary_10_1586_erv_10_117 crossref_primary_10_1016_j_jiph_2009_08_006 crossref_primary_10_1016_j_vaccine_2018_08_030 crossref_primary_10_1016_j_ajic_2017_01_005 crossref_primary_10_1016_j_vaccine_2011_03_045 crossref_primary_10_1016_j_vaccine_2010_07_003 crossref_primary_10_1111_risa_13805 crossref_primary_10_1016_j_annemergmed_2013_07_495 crossref_primary_10_1021_acs_biochem_2c00019 crossref_primary_10_1586_erv_11_154 crossref_primary_10_3928_08910162_20101027_03 crossref_primary_10_1016_j_vaccine_2008_03_045 crossref_primary_10_1038_s41467_022_33909_2 crossref_primary_10_1038_s41598_018_36426_9 crossref_primary_10_1016_j_ajem_2011_07_007 crossref_primary_10_1016_j_vaccine_2011_02_004 crossref_primary_10_1111_irv_12020 crossref_primary_10_1179_2047773214Y_0000000169 crossref_primary_10_1016_j_pedhc_2010_04_007 crossref_primary_10_1186_1471_2334_13_343 crossref_primary_10_18553_jmcp_2015_21_7_568 crossref_primary_10_1186_s12879_016_1939_7 crossref_primary_10_1080_14760584_2019_1640119 crossref_primary_10_1136_bmjopen_2016_014200 crossref_primary_10_3390_healthcare9111411 crossref_primary_10_1128_JVI_00014_14 crossref_primary_10_1016_j_amepre_2016_04_014 crossref_primary_10_1128_JVI_01410_19 crossref_primary_10_1016_j_hlpt_2021_100572 crossref_primary_10_1097_01_PHH_0000296147_17542_0b crossref_primary_10_3934_publichealth_2021030 crossref_primary_10_1007_s40267_015_0202_4 crossref_primary_10_1016_S1473_3099_15_00272_8 crossref_primary_10_1080_24725579_2022_2145393 crossref_primary_10_1111_irv_12019 crossref_primary_10_1111_tbed_13912 crossref_primary_10_1371_journal_pone_0098668 crossref_primary_10_1016_j_vaccine_2016_04_008 crossref_primary_10_1111_irv_12491 crossref_primary_10_1016_j_fitote_2020_104489 crossref_primary_10_1111_j_1750_2659_2010_00154_x crossref_primary_10_1111_risa_12952 crossref_primary_10_1016_j_vaccine_2010_08_026 crossref_primary_10_1111_irv_12254 crossref_primary_10_1016_j_antiviral_2013_09_021 crossref_primary_10_1016_j_exger_2019_110632 crossref_primary_10_1371_journal_ppat_1005095 crossref_primary_10_1016_j_ajic_2017_10_006 crossref_primary_10_1016_j_jbi_2021_103894 crossref_primary_10_1016_S0140_6736_17_30129_0 crossref_primary_10_1071_HC21135 crossref_primary_10_5402_2012_471653 crossref_primary_10_1016_j_amepre_2008_11_016 crossref_primary_10_1093_aje_kwt158 crossref_primary_10_1016_j_eurger_2010_07_002 crossref_primary_10_1111_bcp_13229 crossref_primary_10_1586_14787210_2015_981156 crossref_primary_10_1016_j_puhe_2021_04_007 crossref_primary_10_4155_fmc_2021_0264 crossref_primary_10_1007_s40629_018_0056_0 crossref_primary_10_1016_j_vaccine_2011_10_041 crossref_primary_10_3390_ijerph15050939 crossref_primary_10_1016_j_envint_2020_105668 crossref_primary_10_1017_S0950268815001119 crossref_primary_10_1586_erv_11_133 crossref_primary_10_1371_journal_pone_0233126 crossref_primary_10_1016_j_micinf_2008_07_002 crossref_primary_10_1016_j_ajic_2019_05_009 crossref_primary_10_3389_fimmu_2018_01071 crossref_primary_10_1093_heapro_daw031 crossref_primary_10_2165_00019053_200826110_00004 crossref_primary_10_1080_14760584_2016_1215246 crossref_primary_10_1016_j_landusepol_2009_08_026 crossref_primary_10_1128_AEM_00551_18 crossref_primary_10_1542_peds_2022_057509 crossref_primary_10_1186_s12879_016_1438_x crossref_primary_10_4161_hv_27115 crossref_primary_10_1111_j_1750_2659_2011_00316_x crossref_primary_10_1017_S0950268818000158 crossref_primary_10_1038_s41541_023_00752_5 crossref_primary_10_1371_journal_ppat_1007017 crossref_primary_10_1017_ice_2020_1418 crossref_primary_10_1371_journal_pcbi_1003643 crossref_primary_10_1016_j_jcv_2017_08_004 crossref_primary_10_1093_jpids_piw068 crossref_primary_10_1371_journal_pcbi_1003892 crossref_primary_10_1016_j_healthpol_2012_10_013 crossref_primary_10_1016_j_vaccine_2018_09_040 crossref_primary_10_1016_j_vaccine_2011_04_064 crossref_primary_10_1007_s40265_013_0114_3 crossref_primary_10_1016_j_vaccine_2011_04_067 crossref_primary_10_1128_JVI_02149_19 crossref_primary_10_1038_s41598_018_36361_9 crossref_primary_10_1016_j_compenvurbsys_2010_03_004 crossref_primary_10_1016_j_epidem_2012_06_002 crossref_primary_10_1086_589716 crossref_primary_10_3390_vaccines11101525 crossref_primary_10_1007_s00285_019_01374_z crossref_primary_10_3390_vaccines11101528 crossref_primary_10_18821_0507_4088_2017_62_3_109_114 crossref_primary_10_3390_vaccines3020373 crossref_primary_10_2196_26869 crossref_primary_10_2217_fvl_10_80 crossref_primary_10_1186_1471_2458_11_353 crossref_primary_10_1128_JVI_00349_16 crossref_primary_10_1016_j_vaccine_2011_04_077 crossref_primary_10_1016_j_clml_2016_06_006 crossref_primary_10_1016_j_vaccine_2014_10_079 crossref_primary_10_1371_journal_pone_0026347 crossref_primary_10_4161_hv_28221 crossref_primary_10_1016_j_ajic_2014_03_021 crossref_primary_10_1080_14737159_2017_1372195 crossref_primary_10_1016_j_isci_2022_105877 crossref_primary_10_2196_resprot_5478 crossref_primary_10_1111_irv_12053 crossref_primary_10_1016_j_jaccpubpol_2023_107074 crossref_primary_10_1016_j_vaccine_2013_06_055 crossref_primary_10_3346_jkms_2014_29_4_485 crossref_primary_10_1128_JCM_01639_14 crossref_primary_10_26442_00403660_2020_11_000870 crossref_primary_10_4236_wjv_2014_44018 crossref_primary_10_1128_JVI_02481_15 crossref_primary_10_1021_acscentsci_6b00191 crossref_primary_10_1080_21645515_2023_2257048 crossref_primary_10_1186_1753_6561_9_S9_O12 crossref_primary_10_1371_journal_pone_0195611 crossref_primary_10_1515_spp_2021_0001 crossref_primary_10_1007_s00430_012_0259_9 crossref_primary_10_1128_mBio_02180_19 crossref_primary_10_1371_journal_pone_0118369 crossref_primary_10_1111_j_1750_2659_2012_00422_x crossref_primary_10_3390_ijms18010020 crossref_primary_10_1371_journal_pone_0161193 crossref_primary_10_1586_erv_10_134 crossref_primary_10_1016_j_epidem_2015_03_004 crossref_primary_10_1080_21645515_2019_1706931 crossref_primary_10_1016_j_snb_2021_130392 crossref_primary_10_1007_s13187_016_1017_2 crossref_primary_10_1016_j_virol_2014_04_011 crossref_primary_10_1371_journal_pone_0186914 crossref_primary_10_1128_aac_00009_22 crossref_primary_10_2807_1560_7917_ES_2019_24_12_1800042 crossref_primary_10_1016_j_ajog_2011_04_009 crossref_primary_10_1093_infdis_jiaa292 crossref_primary_10_1016_j_acap_2018_07_003 crossref_primary_10_1080_10106049_2013_799717 crossref_primary_10_1093_aje_kww229 crossref_primary_10_3390_vaccines9070703 crossref_primary_10_1038_nrmicro3367 crossref_primary_10_3390_pathogens8040168 crossref_primary_10_1517_14740338_2015_1053459 crossref_primary_10_1111_jcmm_13467 crossref_primary_10_1016_j_vaccine_2017_07_100 crossref_primary_10_3961_jpmph_19_156 crossref_primary_10_2139_ssrn_3801476 crossref_primary_10_3390_ijerph16050747 crossref_primary_10_1016_j_virol_2014_12_006 crossref_primary_10_33805_2573_3877_146 crossref_primary_10_1128_AAC_00555_08 crossref_primary_10_3389_fimmu_2018_00126 crossref_primary_10_7774_cevr_2018_7_1_1 crossref_primary_10_1126_sciimmunol_aav2026 crossref_primary_10_1016_S2095_3119_20_63468_2 crossref_primary_10_15406_jhvrv_2014_01_00012 crossref_primary_10_1146_annurev_genet_120116_023425 crossref_primary_10_1177_2211068215580935 crossref_primary_10_2139_ssrn_4022672 crossref_primary_10_1016_j_nurpra_2012_11_018 crossref_primary_10_1093_cid_ciq008 crossref_primary_10_1016_j_bjid_2023_102778 crossref_primary_10_1021_acs_biomac_2c00314 crossref_primary_10_1146_annurev_resource_100518_093946 crossref_primary_10_1371_journal_pone_0233526 crossref_primary_10_1542_peds_2010_2376 crossref_primary_10_3390_vaccines10040606 crossref_primary_10_1097_JOM_0000000000000693 crossref_primary_10_1371_journal_pone_0048806 crossref_primary_10_1111_josh_12184 crossref_primary_10_3390_vaccines6020029 crossref_primary_10_1002_agm2_12103 crossref_primary_10_1111_irv_12650 crossref_primary_10_18632_oncotarget_18533 crossref_primary_10_3390_vaccines6030064 crossref_primary_10_1371_journal_pone_0002101 crossref_primary_10_3390_vaccines6020032 crossref_primary_10_51585_gjm_2022_3_0016 crossref_primary_10_1080_21645515_2016_1256928 crossref_primary_10_1057_hs_2014_13 crossref_primary_10_1080_03007995_2019_1584505 crossref_primary_10_1093_infdis_jiad559 crossref_primary_10_14423_SMJ_0000000000001254 crossref_primary_10_1016_j_vaccine_2019_11_009 crossref_primary_10_3390_v12101186 crossref_primary_10_1038_nature13087 crossref_primary_10_1016_j_ypmed_2008_11_001 crossref_primary_10_1145_3486880_3486889 crossref_primary_10_1186_s12889_022_14732_2 crossref_primary_10_1111_irv_12405 crossref_primary_10_3389_fimmu_2018_01479 crossref_primary_10_1088_1674_1056_abcfa5 crossref_primary_10_1016_j_jiac_2023_02_002 crossref_primary_10_1128_CVI_00572_14 crossref_primary_10_1371_journal_ppat_1007892 crossref_primary_10_3390_vaccines9030286 crossref_primary_10_3390_vaccines8020149 crossref_primary_10_1080_21645515_2022_2054602 crossref_primary_10_1016_j_vaccine_2010_07_037 crossref_primary_10_2217_fvl_2016_0142 crossref_primary_10_1016_j_vaccine_2014_11_017 crossref_primary_10_1016_j_amepre_2009_09_032 crossref_primary_10_1016_j_vacun_2016_03_003 crossref_primary_10_1586_14787210_2015_1018183 crossref_primary_10_1080_21645515_2016_1215395 crossref_primary_10_1093_cid_civ952 crossref_primary_10_1097_MLR_0000000000000302 crossref_primary_10_1097_MLR_0000000000000544 crossref_primary_10_1111_jcmm_15672 crossref_primary_10_4049_immunohorizons_2100046 crossref_primary_10_1371_journal_ppat_1003059 crossref_primary_10_1097_AOG_0b013e318242af27 crossref_primary_10_1016_j_vaccine_2008_11_070 crossref_primary_10_1371_journal_pone_0024579 crossref_primary_10_1111_irv_12470 crossref_primary_10_1111_j_1750_2659_2009_00095_x crossref_primary_10_1016_j_diagmicrobio_2018_03_013 crossref_primary_10_1016_j_prevetmed_2023_106083 crossref_primary_10_1080_21645515_2017_1377376 crossref_primary_10_1016_j_vaccine_2019_06_066 crossref_primary_10_1080_14760584_2024_2348608 crossref_primary_10_1097_QAD_0b013e328349f067 crossref_primary_10_1093_cid_cit549 crossref_primary_10_1007_s40520_022_02110_2 crossref_primary_10_1016_j_vaccine_2015_07_023 crossref_primary_10_1016_j_virusres_2014_05_003 crossref_primary_10_1007_s11280_018_0608_8 crossref_primary_10_1177_1757177418772184 crossref_primary_10_1371_journal_pone_0172261 crossref_primary_10_1371_journal_pone_0165729 crossref_primary_10_1080_03007995_2020_1839400 crossref_primary_10_1016_j_bios_2015_04_078 crossref_primary_10_3390_cells12151937 crossref_primary_10_1371_journal_pone_0172012 crossref_primary_10_3389_fimmu_2018_00323 crossref_primary_10_1128_jvi_00154_23 crossref_primary_10_1016_j_vaccine_2017_02_044 crossref_primary_10_12788_jhm_2824 crossref_primary_10_4161_hv_8_1_17622 crossref_primary_10_4161_hv_29393 crossref_primary_10_1186_s12873_016_0080_7 crossref_primary_10_1097_MLR_0000000000000523 crossref_primary_10_2105_AJPH_2013_301514 crossref_primary_10_2105_AJPH_2016_303142 crossref_primary_10_1016_j_vaccine_2010_07_009 crossref_primary_10_1111_irv_12696 crossref_primary_10_1016_S2468_2667_17_30004_X crossref_primary_10_1111_irv_12691 crossref_primary_10_1016_j_amepre_2015_09_028 crossref_primary_10_1097_EBP_0000000000000627 crossref_primary_10_1016_j_amepre_2009_08_012 crossref_primary_10_1371_journal_ppat_1005692 crossref_primary_10_17269_cjph_105_4346 crossref_primary_10_1111_irv_12694 crossref_primary_10_1016_j_jconrel_2018_09_020 crossref_primary_10_1016_j_vaccine_2013_04_052 crossref_primary_10_1097_INF_0b013e3182481ef8 crossref_primary_10_1016_j_vaccine_2008_06_087 crossref_primary_10_1007_s11248_017_0047_9 crossref_primary_10_1128_JVI_00841_21 crossref_primary_10_1177_0883073813480243 crossref_primary_10_1016_j_npg_2012_03_001 crossref_primary_10_1016_j_vaccine_2010_07_029 crossref_primary_10_1016_j_vaccine_2015_07_049 crossref_primary_10_1016_j_vaccine_2008_05_053 crossref_primary_10_1177_216507991206001103 crossref_primary_10_1002_jcph_299 crossref_primary_10_1056_NEJMcp0807498 crossref_primary_10_1007_s41885_021_00083_6 crossref_primary_10_1111_irv_12201 crossref_primary_10_1007_s40954_017_0068_x crossref_primary_10_1007_s11239_019_02016_3 crossref_primary_10_1016_j_gene_2021_145854 crossref_primary_10_1155_2012_806198 crossref_primary_10_1016_j_chom_2013_02_008 crossref_primary_10_1016_j_vaccine_2019_11_040 crossref_primary_10_1097_JOM_0b013e3181f43844 crossref_primary_10_1093_cid_ciu425 crossref_primary_10_1586_erv_09_7 crossref_primary_10_1016_j_str_2015_08_007 crossref_primary_10_1016_j_virol_2010_02_001 crossref_primary_10_15789_2220_7619_2014_3_257_266 crossref_primary_10_1080_13696998_2024_2314429 crossref_primary_10_1016_j_semcdb_2018_07_018 crossref_primary_10_1097_JSM_0000000000000808 crossref_primary_10_4161_21645515_2014_982998 crossref_primary_10_1371_journal_pone_0084961 crossref_primary_10_1002_jmv_25593 crossref_primary_10_1016_j_jaut_2014_07_005 crossref_primary_10_1097_QCO_0b013e3283013945 crossref_primary_10_1016_j_cellimm_2019_103992 crossref_primary_10_3389_fpubh_2023_1307425 crossref_primary_10_3390_vaccines9070787 crossref_primary_10_1038_s41598_018_30079_4 crossref_primary_10_1038_s41426_018_0115_0 crossref_primary_10_1186_1741_7015_7_13 crossref_primary_10_1016_j_vaccine_2012_09_071 crossref_primary_10_1016_j_vaccine_2017_09_016 crossref_primary_10_1016_j_amjmed_2008_05_002 crossref_primary_10_1080_14760584_2016_1254044 crossref_primary_10_9778_cmajo_20180189 crossref_primary_10_1111_j_1539_6924_2012_01938_x crossref_primary_10_1111_irv_12935 crossref_primary_10_2471_BLT_11_090209 crossref_primary_10_1016_j_coi_2018_04_001 crossref_primary_10_1186_1471_2458_12_878 crossref_primary_10_3389_fimmu_2019_02005 crossref_primary_10_3390_v11020190 crossref_primary_10_1371_journal_pone_0072723 crossref_primary_10_1007_s10198_018_0978_y crossref_primary_10_1080_13547860_2012_639999 crossref_primary_10_1016_j_ajic_2016_03_019 crossref_primary_10_1111_irv_12700 crossref_primary_10_1093_jnci_djn384 crossref_primary_10_1016_S1553_7250_12_38009_4 crossref_primary_10_1017_S0950268816000315 crossref_primary_10_1128_JVI_01565_14 crossref_primary_10_1093_aje_kwz248 crossref_primary_10_1016_j_antiviral_2019_02_003 crossref_primary_10_1186_s12879_021_07021_7 crossref_primary_10_1016_j_annemergmed_2009_09_019 crossref_primary_10_1080_14760584_2016_1221347 crossref_primary_10_1021_acs_biochem_0c00666 crossref_primary_10_1016_j_ijid_2020_02_040 crossref_primary_10_1016_j_puhe_2011_03_004 crossref_primary_10_1128_mSphereDirect_00549_18 crossref_primary_10_1586_14760584_2015_1078732 crossref_primary_10_1016_j_vaccine_2024_03_063 crossref_primary_10_1016_j_vaccine_2010_06_097 crossref_primary_10_1371_journal_pone_0068019 crossref_primary_10_1177_00333549121270S101 crossref_primary_10_1080_21645515_2016_1242541 crossref_primary_10_1111_j_1750_2659_2011_00288_x crossref_primary_10_3390_vaccines9070769 crossref_primary_10_1016_j_nurpra_2014_10_023 crossref_primary_10_1097_JOM_0000000000000738 crossref_primary_10_1017_ice_2019_305 crossref_primary_10_1177_1054773811409032 crossref_primary_10_1017_S1466252312000217 crossref_primary_10_1134_S2079086417040065 crossref_primary_10_2215_CJN_00150110 crossref_primary_10_1016_j_vaccine_2020_09_033 crossref_primary_10_1021_acs_est_3c07526 crossref_primary_10_1016_j_amjopharm_2010_05_003 crossref_primary_10_1007_s40520_020_01688_9 crossref_primary_10_1016_j_tmaid_2013_10_016 crossref_primary_10_3390_v11060548 crossref_primary_10_1016_j_eimc_2013_05_001 crossref_primary_10_1017_S0950268815000941 crossref_primary_10_2196_16373 crossref_primary_10_1128_JVI_00410_16 crossref_primary_10_1016_j_arr_2010_09_005 crossref_primary_10_1080_22221751_2022_2135460 crossref_primary_10_1371_journal_pcbi_1008470 crossref_primary_10_3389_fmed_2023_1117885 crossref_primary_10_1111_ina_12267 crossref_primary_10_1186_s12879_019_3681_4 crossref_primary_10_4140_TCP_n_2009_380 crossref_primary_10_1111_jphp_12350 crossref_primary_10_1089_jir_2012_0119 crossref_primary_10_1080_21645515_2015_1062189 crossref_primary_10_1371_journal_pone_0021471 crossref_primary_10_1093_ofid_ofad599 crossref_primary_10_1214_18_BA1117 crossref_primary_10_1016_j_ejpb_2017_11_001 crossref_primary_10_1637_11852_042018_Reg_1 crossref_primary_10_1111_irv_12994 crossref_primary_10_1016_j_virol_2020_08_004 crossref_primary_10_1371_journal_pone_0010583 crossref_primary_10_1007_s10796_018_9893_0 crossref_primary_10_1517_14712591003724662 crossref_primary_10_1093_occmed_kqu022 crossref_primary_10_1016_j_vaccine_2013_02_052 crossref_primary_10_1016_j_vaccine_2010_05_011 crossref_primary_10_1053_j_ajkd_2010_12_016 crossref_primary_10_1186_s12879_020_4948_5 crossref_primary_10_4161_hv_22231 crossref_primary_10_1111_risa_13209 crossref_primary_10_1111_irv_12737 crossref_primary_10_1007_s43069_022_00176_2 crossref_primary_10_1038_s41598_017_14823_w crossref_primary_10_1371_journal_pone_0020130 crossref_primary_10_3390_v6062465 crossref_primary_10_1093_jpids_piaa073 crossref_primary_10_1073_pnas_1415396111 crossref_primary_10_1016_j_semerg_2022_03_012 crossref_primary_10_1371_journal_pone_0022308 crossref_primary_10_1016_j_ehb_2019_04_004 crossref_primary_10_1111_irv_12505 crossref_primary_10_1016_j_vaccine_2021_04_016 crossref_primary_10_1016_j_vaccine_2021_06_085 crossref_primary_10_3390_biom5031480 crossref_primary_10_1080_15459624_2015_1096363 crossref_primary_10_1016_j_vaccine_2020_08_011 crossref_primary_10_1016_j_bios_2019_111476 crossref_primary_10_3928_21650799_20121016_67 crossref_primary_10_3390_ijms25042061 crossref_primary_10_1016_j_bbrc_2023_08_027 crossref_primary_10_1016_j_vaccine_2019_08_064 crossref_primary_10_1016_j_bjid_2021_101609 crossref_primary_10_4161_hv_8_1_18672 crossref_primary_10_1093_infdis_jiv264 crossref_primary_10_1016_j_cie_2021_107327 crossref_primary_10_1080_21645515_2017_1405883 crossref_primary_10_1093_ofid_ofac489 crossref_primary_10_1080_14760584_2023_2295014 crossref_primary_10_1016_j_addr_2014_11_004 crossref_primary_10_1038_s41598_022_10559_4 crossref_primary_10_1016_j_pep_2024_106506 crossref_primary_10_2139_ssrn_3330631 crossref_primary_10_1016_S1701_2163_16_35336_1 crossref_primary_10_1186_s12879_015_1167_6 crossref_primary_10_1093_ajhp_zxab099 crossref_primary_10_1016_j_bbrc_2018_05_148 crossref_primary_10_1007_s40258_013_0020_6 crossref_primary_10_3389_fviro_2022_1049134 crossref_primary_10_1016_j_jadohealth_2017_09_021 crossref_primary_10_1017_S0950268818000705 crossref_primary_10_1016_S1473_3099_20_30459_X crossref_primary_10_2139_ssrn_3135479 crossref_primary_10_1016_j_vaccine_2010_05_036 crossref_primary_10_1371_journal_ppat_1004869 crossref_primary_10_1093_cid_cix524 crossref_primary_10_1016_j_anai_2020_04_008 crossref_primary_10_1111_irv_12963 crossref_primary_10_1371_journal_pone_0168262 crossref_primary_10_3390_v13020344 crossref_primary_10_1016_j_vaccine_2017_05_093 crossref_primary_10_2807_1560_7917_ES2014_19_16_20780 crossref_primary_10_1016_j_epidem_2020_100415 crossref_primary_10_1097_JOM_0000000000001878 crossref_primary_10_1007_s40121_015_0076_8 crossref_primary_10_2196_14337 crossref_primary_10_1017_S0950268818000596 crossref_primary_10_1021_acs_analchem_6b04801 crossref_primary_10_1016_j_lpm_2012_05_017 crossref_primary_10_1101_cshperspect_a028845 crossref_primary_10_1073_pnas_1324197111 crossref_primary_10_1093_cid_ciy866 crossref_primary_10_1080_21645515_2022_2069974 crossref_primary_10_1371_journal_pone_0124677 crossref_primary_10_35366_114226 crossref_primary_10_4161_hv_24209 crossref_primary_10_1016_j_vaccine_2015_01_059 crossref_primary_10_1016_j_datak_2023_102256 crossref_primary_10_1074_jbc_RA119_011410 crossref_primary_10_1002_pro_3319 crossref_primary_10_1016_j_vaccine_2011_12_027 crossref_primary_10_1186_1471_2393_14_19 crossref_primary_10_1371_journal_pone_0241725 crossref_primary_10_3810_psm_2010_12_1823 crossref_primary_10_1371_journal_pone_0169344 crossref_primary_10_1016_j_jinf_2017_09_010 crossref_primary_10_1542_peds_2007_2963 crossref_primary_10_1152_japplphysiol_01355_2012 crossref_primary_10_1586_erv_12_61 crossref_primary_10_1093_cid_ciaa782 crossref_primary_10_1093_cid_ciy874 crossref_primary_10_1128_JVI_00030_19 crossref_primary_10_1096_fj_14_268755 crossref_primary_10_1165_rcmb_2009_0158ED crossref_primary_10_1371_journal_pone_0159780 crossref_primary_10_1111_nyas_12012 crossref_primary_10_1016_j_tvjl_2014_10_015 crossref_primary_10_1016_j_jinf_2008_10_005 crossref_primary_10_1128_JVI_01579_17 crossref_primary_10_1007_s40258_019_00534_y crossref_primary_10_1093_infdis_jis578 crossref_primary_10_1128_JVI_01847_14 crossref_primary_10_3389_fmicb_2021_735305 crossref_primary_10_1128_AEM_04046_15 crossref_primary_10_3390_vaccines10040495 crossref_primary_10_1016_j_jcv_2016_09_006 crossref_primary_10_1080_21645515_2019_1707006 crossref_primary_10_1002_cpe_3287 crossref_primary_10_1073_pnas_1909613116 crossref_primary_10_1016_j_vaccine_2017_08_064 crossref_primary_10_1186_s12879_014_0694_x crossref_primary_10_1186_s12879_017_2863_1 crossref_primary_10_1111_ped_13428 crossref_primary_10_30699_jergon_8_4_69 crossref_primary_10_1186_s12879_014_0670_5 crossref_primary_10_20960_nh_2303 crossref_primary_10_1016_j_vaccine_2021_01_016 crossref_primary_10_1097_JOM_0b013e3182717d13 crossref_primary_10_1371_journal_pone_0270086 crossref_primary_10_1109_TBCAS_2009_2020693 crossref_primary_10_1016_j_vaccine_2008_09_086 crossref_primary_10_1111_irv_12094 crossref_primary_10_1136_bmjopen_2018_022949 crossref_primary_10_4161_hv_26886 crossref_primary_10_1016_j_vaccine_2015_02_076 crossref_primary_10_1039_C4AN01352B crossref_primary_10_2139_ssrn_2646870 crossref_primary_10_1016_j_pedn_2018_05_009 crossref_primary_10_1371_journal_pone_0213499 crossref_primary_10_3390_nu14061195 crossref_primary_10_1002_sim_9219 crossref_primary_10_1016_j_jcv_2014_06_001 crossref_primary_10_3390_ijerph7030853 crossref_primary_10_2217_ahe_09_35 crossref_primary_10_2165_00019053_200927060_00001 crossref_primary_10_1097_01_NAJ_0000361490_52718_cf crossref_primary_10_1371_journal_pone_0076708 crossref_primary_10_1186_1756_0500_6_330 crossref_primary_10_1016_j_vaccine_2017_08_078 crossref_primary_10_1128_JCM_02136_14 crossref_primary_10_1371_journal_pone_0294260 crossref_primary_10_1016_j_vaccine_2016_12_063 crossref_primary_10_1016_j_vaccine_2017_06_074 crossref_primary_10_1152_ajplung_00105_2013 crossref_primary_10_1016_j_vaccine_2015_04_064 crossref_primary_10_1097_EDE_0000000000000646 crossref_primary_10_1080_15459624_2019_1691219 crossref_primary_10_1177_1559827616631723 crossref_primary_10_3390_ijerph14080849 crossref_primary_10_1016_j_vaccine_2012_05_021 crossref_primary_10_1038_s41598_024_58690_8 crossref_primary_10_1542_peds_2011_0737D crossref_primary_10_1016_j_vaccine_2021_03_041 crossref_primary_10_1111_1475_6773_12786 crossref_primary_10_1080_07448481_2021_1973480 crossref_primary_10_1016_j_cellimm_2020_104149 crossref_primary_10_1007_s00705_013_1922_1 crossref_primary_10_1016_S1473_3099_21_00702_7 crossref_primary_10_1371_journal_pone_0250417 crossref_primary_10_1007_s11606_021_06941_z crossref_primary_10_1016_j_jtbi_2020_110566 crossref_primary_10_1111_j_1750_2659_2011_00240_x crossref_primary_10_1111_ina_12673 crossref_primary_10_1111_jcmm_13943 crossref_primary_10_1016_j_jep_2020_112671 crossref_primary_10_1016_j_jbi_2018_02_014 crossref_primary_10_1128_JVI_01042_18 crossref_primary_10_1186_s12879_018_3425_x crossref_primary_10_1080_03007995_2017_1381078 crossref_primary_10_1097_JOM_0b013e3181fd32e4 crossref_primary_10_1016_j_virol_2012_06_002 crossref_primary_10_1371_journal_pone_0009966 crossref_primary_10_1128_microbiolspec_DMIH2_0028_2016 crossref_primary_10_1016_j_ccc_2013_03_009 crossref_primary_10_1371_journal_pone_0028001 crossref_primary_10_1080_22221751_2019_1581034 crossref_primary_10_1016_j_sapharm_2018_04_015 crossref_primary_10_1371_journal_pcbi_1005330 crossref_primary_10_3201_eid2109_141912 crossref_primary_10_1038_srep21812 crossref_primary_10_3390_v15122446 crossref_primary_10_1371_journal_pone_0204337 crossref_primary_10_2139_ssrn_4114706 crossref_primary_10_3201_eid1609_100076 crossref_primary_10_1080_21645515_2021_1908797 crossref_primary_10_1111_resp_12685 crossref_primary_10_1016_j_pmedr_2019_100893 crossref_primary_10_3201_eid1602_091375 crossref_primary_10_1093_pnasnexus_pgac143 crossref_primary_10_1080_15548627_2020_1725375 crossref_primary_10_1111_ped_12526 crossref_primary_10_1128_JVI_00032_19 crossref_primary_10_1016_j_ejmech_2015_04_030 crossref_primary_10_1099_jgv_0_001128 crossref_primary_10_1016_S1473_3099_20_30004_9 crossref_primary_10_1080_21645515_2017_1321722 crossref_primary_10_1086_675832 crossref_primary_10_1165_rcmb_2018_0247TR crossref_primary_10_1021_acsinfecdis_9b00230 crossref_primary_10_1038_srep03152 crossref_primary_10_2196_13403 crossref_primary_10_1016_j_vaccine_2018_01_050 crossref_primary_10_3390_v15102063 crossref_primary_10_1371_journal_pone_0166107 crossref_primary_10_2139_ssrn_3562053 crossref_primary_10_1111_josh_12484 crossref_primary_10_1016_j_psj_2024_103800 crossref_primary_10_1080_21645515_2017_1356526 crossref_primary_10_1111_j_1750_2659_2012_00378_x crossref_primary_10_1038_nsmb_2524 crossref_primary_10_1186_1471_2458_14_56 crossref_primary_10_1371_journal_pone_0017579 crossref_primary_10_1371_journal_pone_0195903 crossref_primary_10_1111_j_1750_2659_2008_00037_x crossref_primary_10_1016_j_clim_2013_12_008 crossref_primary_10_3390_v12020167 crossref_primary_10_3111_13696990802505557 crossref_primary_10_2139_ssrn_1073143 crossref_primary_10_3851_IMP3158 crossref_primary_10_1371_journal_pone_0007776 crossref_primary_10_1016_j_vaccine_2017_07_069 crossref_primary_10_1177_2165079916657107 crossref_primary_10_1016_j_vaccine_2010_01_034 crossref_primary_10_1515_jom_2022_0138 crossref_primary_10_1542_peds_2022_056967 crossref_primary_10_1002_ijgo_14798 crossref_primary_10_1097_01720610_201201000_00006 crossref_primary_10_1007_s11596_021_2493_0 crossref_primary_10_3390_vaccines3020293 crossref_primary_10_1038_ni_3046 crossref_primary_10_1371_journal_pone_0133888 crossref_primary_10_1371_journal_pone_0202787 crossref_primary_10_1189_jlb_1011506 crossref_primary_10_1016_j_vaccine_2020_06_065 crossref_primary_10_1038_gene_2016_34 crossref_primary_10_1016_j_japh_2021_05_014 crossref_primary_10_1586_erv_09_118 crossref_primary_10_2217_fvl_12_117 crossref_primary_10_1080_14760584_2019_1575734 crossref_primary_10_1177_0033354918805720 crossref_primary_10_1186_s12913_022_08586_y crossref_primary_10_1128_JVI_01523_15 crossref_primary_10_18553_jmcp_2020_26_1_42 crossref_primary_10_1007_s00125_013_3158_8 crossref_primary_10_1016_j_antiviral_2018_03_005 crossref_primary_10_3390_microorganisms8111745 crossref_primary_10_1016_j_vaccine_2017_07_050 crossref_primary_10_1111_irv_12138 crossref_primary_10_1186_s12889_022_13962_8 crossref_primary_10_1517_14712598_2011_541436 crossref_primary_10_1016_j_infoandorg_2023_100452 crossref_primary_10_1093_abm_kaaa017 crossref_primary_10_1016_j_ypmed_2019_105949 crossref_primary_10_3402_ehtj_v4i0_7108 crossref_primary_10_3390_vaccines8010052 crossref_primary_10_1016_j_virol_2015_08_004 crossref_primary_10_1186_s12985_023_02115_x crossref_primary_10_1007_s10640_024_00858_x crossref_primary_10_1111_jgs_14976 crossref_primary_10_1186_s12879_018_3444_7 crossref_primary_10_1371_journal_pcbi_1003583 crossref_primary_10_1371_journal_pcbi_1005521 crossref_primary_10_1016_j_mayocpiqo_2021_07_005 crossref_primary_10_1038_s41572_018_0002_y crossref_primary_10_1186_s12916_021_01926_5 crossref_primary_10_1016_j_health_2022_100042 crossref_primary_10_1089_jir_2017_0032 crossref_primary_10_1016_j_ejphar_2017_10_035 crossref_primary_10_1016_j_epidem_2011_04_002 crossref_primary_10_1097_PHH_0000000000000195 crossref_primary_10_1016_j_annepidem_2021_07_008 crossref_primary_10_1080_24725579_2017_1418768 crossref_primary_10_1093_infdis_jis641 crossref_primary_10_2119_molmed_2012_00147 crossref_primary_10_1177_0009922809351962 crossref_primary_10_3310_hsdr01100 crossref_primary_10_3390_vaccines10040582 crossref_primary_10_1093_bmb_ldaa036 crossref_primary_10_1007_s10198_014_0586_4 crossref_primary_10_3934_mbe_2018006 crossref_primary_10_2196_12341 crossref_primary_10_1371_journal_pone_0216983 crossref_primary_10_1093_cid_cir644 crossref_primary_10_1016_j_amepre_2009_11_011 crossref_primary_10_1016_j_virusres_2015_11_014 crossref_primary_10_5334_aogh_2423 crossref_primary_10_1016_j_coviro_2019_01_006 crossref_primary_10_1099_vir_0_011270_0 crossref_primary_10_1128_CMR_00027_10 crossref_primary_10_1186_1471_2334_10_71 crossref_primary_10_1111_irv_12184 crossref_primary_10_1371_journal_pone_0222178 crossref_primary_10_1080_14787210_2021_1878025 crossref_primary_10_1016_j_hlpt_2017_02_001 crossref_primary_10_1111_irv_13035 crossref_primary_10_1016_j_vaccine_2014_06_005 crossref_primary_10_1016_j_vaccine_2012_04_057 crossref_primary_10_1016_j_focus_2024_100248 crossref_primary_10_1016_j_apgeog_2014_02_005 crossref_primary_10_1016_j_cppeds_2010_01_003 crossref_primary_10_3390_vaccines8010085 crossref_primary_10_3923_jpt_2016_27_32 crossref_primary_10_1111_j_1750_2659_2011_00270_x crossref_primary_10_3109_00365541003699649 crossref_primary_10_1371_journal_pone_0031696 crossref_primary_10_3389_fmicb_2018_01826 crossref_primary_10_1038_nm_4224 crossref_primary_10_1128_jvi_01982_21 crossref_primary_10_1016_j_ypmed_2014_09_009 crossref_primary_10_1186_1471_2334_14_231 crossref_primary_10_1186_s12889_015_1685_6 crossref_primary_10_1007_s11764_012_0257_3 crossref_primary_10_1080_21645515_2017_1343226 crossref_primary_10_1096_fj_11_193466 crossref_primary_10_1371_journal_pone_0066316 crossref_primary_10_1016_j_vaccine_2015_11_032 crossref_primary_10_1016_j_annemergmed_2013_01_005 crossref_primary_10_1016_j_ijid_2019_03_020 crossref_primary_10_1080_21645515_2017_1345400 crossref_primary_10_1177_15270025221143978 crossref_primary_10_1007_s40121_020_00354_x crossref_primary_10_1177_2515135519885547 crossref_primary_10_1016_j_cct_2023_107103 crossref_primary_10_1186_s12879_015_1193_4 crossref_primary_10_3390_v7010154 crossref_primary_10_1186_s12889_020_09409_7 crossref_primary_10_1007_s00477_014_0974_4 crossref_primary_10_1007_s11606_017_4266_9 crossref_primary_10_1128_JCM_00155_20 crossref_primary_10_1021_acs_analchem_8b02479 crossref_primary_10_1016_j_compbiomed_2021_104482 crossref_primary_10_1128_JVI_01283_17 crossref_primary_10_1097_JOM_0000000000001076 crossref_primary_10_1007_s11524_010_9541_6 crossref_primary_10_1097_PEC_0000000000001243 crossref_primary_10_1108_IJLM_12_2015_0227 crossref_primary_10_1145_3380971 crossref_primary_10_1186_2045_4015_3_13 crossref_primary_10_1152_ajplung_00283_2020 crossref_primary_10_1016_j_jhin_2020_03_023 crossref_primary_10_1371_journal_ppat_1010505 crossref_primary_10_2105_AJPH_2012_301137 crossref_primary_10_1016_j_vaccine_2014_07_078 crossref_primary_10_1089_vim_2017_0146 crossref_primary_10_4236_aid_2015_54026 crossref_primary_10_1016_S1473_3099_15_00249_2 crossref_primary_10_1002_14651858_CD004974_pub2 crossref_primary_10_3389_fimmu_2016_00195 crossref_primary_10_1128_JCM_01945_17 crossref_primary_10_1093_ve_vead020 crossref_primary_10_1016_j_sste_2021_100458 crossref_primary_10_1111_jgs_14588 crossref_primary_10_1038_msb_2013_15 crossref_primary_10_2139_ssrn_4405464 crossref_primary_10_1073_pnas_1900784116 crossref_primary_10_1016_j_vaccine_2020_04_045 crossref_primary_10_1371_journal_pone_0077244 crossref_primary_10_1007_s40276_013_0016_0 crossref_primary_10_1016_j_vaccine_2023_10_039 crossref_primary_10_1128_mBio_01463_17 crossref_primary_10_1186_s12979_020_00181_1 crossref_primary_10_1590_0037_8682_0167_2022 crossref_primary_10_1016_j_artmed_2013_09_001 crossref_primary_10_1016_j_clinthera_2010_07_019 crossref_primary_10_1016_j_jval_2020_10_013 crossref_primary_10_2196_jmir_3532 crossref_primary_10_1093_jpids_piv041 crossref_primary_10_1080_14737167_2021_1925110 crossref_primary_10_1111_cas_14742 crossref_primary_10_1128_JCM_00957_17 crossref_primary_10_1371_journal_pone_0293504 crossref_primary_10_2147_JAA_S277455 crossref_primary_10_1111_twec_12296 crossref_primary_10_2165_00151234_200705340_00009 crossref_primary_10_1111_1751_7915_12835 crossref_primary_10_7717_peerj_9432 crossref_primary_10_1038_s41586_018_0238_4 crossref_primary_10_1038_s41564_017_0011_8 crossref_primary_10_1093_ve_vev025 crossref_primary_10_1002_cjce_24557 crossref_primary_10_1016_j_vaccine_2018_02_027 crossref_primary_10_1007_s11908_012_0236_x crossref_primary_10_1002_ebch_1833 crossref_primary_10_1186_s12879_019_3750_8 crossref_primary_10_1080_21645515_2017_1415684 crossref_primary_10_18527_2500_2236_2016_3_1_31_41 crossref_primary_10_1016_j_idh_2016_12_005 crossref_primary_10_1007_s10096_010_1002_3 crossref_primary_10_1016_j_tips_2011_09_001 crossref_primary_10_1016_j_healthpol_2016_04_015 crossref_primary_10_21769_BioProtoc_3062 crossref_primary_10_1016_j_ijpharm_2022_122429 crossref_primary_10_4269_ajtmh_17_0032 crossref_primary_10_1200_JCO_2009_26_6908 crossref_primary_10_1007_s11538_022_01114_3 crossref_primary_10_1093_infdis_jiab485 crossref_primary_10_1111_jgs_14323 crossref_primary_10_1126_scitranslmed_3005996 crossref_primary_10_1128_JVI_03004_13 crossref_primary_10_2217_fvl_15_44 crossref_primary_10_1186_s12889_016_2884_5 crossref_primary_10_1016_j_rdc_2012_08_016 crossref_primary_10_1007_s00705_019_04300_2 crossref_primary_10_1099_jgv_0_000758 crossref_primary_10_1016_j_vaccine_2018_10_027 crossref_primary_10_1097_INF_0000000000002387 crossref_primary_10_1038_srep00357 crossref_primary_10_3390_children1020208 crossref_primary_10_1186_1471_2458_14_718 crossref_primary_10_1287_mnsc_2021_4051 crossref_primary_10_1371_journal_pone_0156929 crossref_primary_10_1111_irv_12521 crossref_primary_10_1186_s40545_021_00367_y crossref_primary_10_1017_S0959259810000377 crossref_primary_10_1016_j_vaccine_2020_12_075 crossref_primary_10_1155_2020_7351398 crossref_primary_10_2217_fvl_15_31 crossref_primary_10_1016_j_jconrel_2022_05_017 crossref_primary_10_3390_vaccines9080851 crossref_primary_10_4137_CMO_S13774 crossref_primary_10_1016_j_bjid_2017_11_004 crossref_primary_10_1016_j_jpap_2021_100072 crossref_primary_10_1007_s11538_021_00988_z crossref_primary_10_1016_j_amjcard_2020_05_045 crossref_primary_10_1016_j_jiph_2017_05_001 crossref_primary_10_3390_v6103809 crossref_primary_10_1001_jamanetworkopen_2018_0143 crossref_primary_10_1186_1471_2334_14_297 crossref_primary_10_1016_j_jemermed_2009_11_031 crossref_primary_10_1186_s12913_019_4228_5 crossref_primary_10_1111_irv_12357 crossref_primary_10_1186_s12889_019_7966_8 crossref_primary_10_1128_AEM_06960_11 crossref_primary_10_1097_JOM_0000000000000115 crossref_primary_10_1177_216507991005801101 crossref_primary_10_1186_s12879_016_2177_8 crossref_primary_10_1542_peds_2016_1746 crossref_primary_10_1177_0148607113514612 crossref_primary_10_1111_irv_12359 crossref_primary_10_2217_fvl_13_85 crossref_primary_10_1128_AAC_00476_09 crossref_primary_10_1111_risa_12854 crossref_primary_10_3390_ijms21041511 crossref_primary_10_1371_journal_pone_0132922 crossref_primary_10_3390_cells8070654 crossref_primary_10_1186_2046_4053_1_35 crossref_primary_10_1097_INF_0b013e3182918168 crossref_primary_10_12688_f1000research_19090_1 crossref_primary_10_1080_00045608_2012_674844 crossref_primary_10_3201_eid2813_212303 crossref_primary_10_1016_j_virusres_2015_07_013 crossref_primary_10_1371_journal_pone_0154970 crossref_primary_10_1016_j_amepre_2018_11_015 crossref_primary_10_1007_s15007_018_1580_4 crossref_primary_10_1016_j_vaccine_2014_05_015 crossref_primary_10_1074_jbc_RA118_004012 crossref_primary_10_1016_j_heliyon_2023_e14649 crossref_primary_10_1016_j_vaccine_2012_01_027 crossref_primary_10_1016_j_vaccine_2011_08_015 crossref_primary_10_1248_cpb_c19_00485 crossref_primary_10_1016_j_iac_2019_03_007 crossref_primary_10_1007_s10935_015_0394_3 crossref_primary_10_1016_j_ejmech_2024_116469 crossref_primary_10_1016_j_vaccine_2009_06_032 crossref_primary_10_1128_JVI_01164_17 crossref_primary_10_3390_vaccines9030188 crossref_primary_10_2217_fvl_13_118 crossref_primary_10_3390_vaccines8010005 crossref_primary_10_1016_j_vaccine_2018_03_047 crossref_primary_10_1109_TPAMI_2016_2605095 crossref_primary_10_1016_j_ajic_2014_09_003 crossref_primary_10_1016_j_vaccine_2020_05_021 crossref_primary_10_2196_publichealth_6648 crossref_primary_10_1038_s41541_017_0020_x crossref_primary_10_1097_01_NUMA_0000526065_48135_5f crossref_primary_10_1109_ACCESS_2018_2882915 crossref_primary_10_1016_j_ogc_2014_08_002 crossref_primary_10_1086_675281 crossref_primary_10_1186_s12879_019_4186_x crossref_primary_10_1016_j_vaccine_2014_04_003 crossref_primary_10_1111_irv_12330 crossref_primary_10_1080_07448481_2018_1440582 crossref_primary_10_1093_infdis_jix292 crossref_primary_10_1093_aje_kwx037 crossref_primary_10_1186_s12889_016_3297_1 crossref_primary_10_1186_s12889_015_1885_0 crossref_primary_10_1186_s12875_021_01519_4 crossref_primary_10_1016_j_vaccine_2014_05_032 crossref_primary_10_1111_irv_12319 crossref_primary_10_1080_10911359_2014_884963 crossref_primary_10_1016_j_onehlt_2015_03_001 crossref_primary_10_1016_j_carbon_2021_07_004 crossref_primary_10_1097_INF_0b013e318257172d crossref_primary_10_1111_risa_12625 crossref_primary_10_3390_ijerph18126277 crossref_primary_10_1016_j_orhc_2015_05_003 crossref_primary_10_1371_journal_pcbi_1011317 crossref_primary_10_1016_j_jep_2023_116322 crossref_primary_10_1016_j_ympev_2008_02_003 crossref_primary_10_1016_j_vaccine_2018_04_027 crossref_primary_10_3389_fpubh_2023_1030391 crossref_primary_10_1007_s00285_019_01401_z crossref_primary_10_1086_650449 crossref_primary_10_1016_j_ajem_2019_12_057 crossref_primary_10_1016_j_jpeds_2021_01_021 crossref_primary_10_1093_aje_kwy254 crossref_primary_10_1016_j_epidem_2019_01_002 crossref_primary_10_2105_AJPH_2009_161125 crossref_primary_10_3390_vaccines8030434 crossref_primary_10_1097_JPN_0000000000000068 crossref_primary_10_1128_mBio_01156_15 crossref_primary_10_1136_bmjopen_2015_010133 crossref_primary_10_1016_j_cmi_2016_09_003 crossref_primary_10_1002_pbc_23113 crossref_primary_10_18527_2500_2236_2016_3_1_1_12 crossref_primary_10_1002_hec_3379 crossref_primary_10_3389_fmolb_2022_1017338 crossref_primary_10_1371_journal_pone_0067260 crossref_primary_10_3389_fimmu_2019_00180 crossref_primary_10_1016_j_vaccine_2013_09_012 crossref_primary_10_1128_JVI_01025_18 crossref_primary_10_1016_j_idh_2019_01_003 crossref_primary_10_1016_j_vaccine_2013_09_013 crossref_primary_10_3390_ijerph20021074 crossref_primary_10_1016_j_vaccine_2012_10_084 crossref_primary_10_1071_AH19196 crossref_primary_10_1111_irv_12822 crossref_primary_10_1136_jech_2019_212488 crossref_primary_10_1186_s12889_019_6773_6 crossref_primary_10_1063_5_0169834 crossref_primary_10_1099_jmm_0_001133 crossref_primary_10_1080_13696998_2021_1965732 crossref_primary_10_1016_j_jep_2022_115175 crossref_primary_10_1186_1476_072X_11_16 crossref_primary_10_1016_j_emc_2011_10_011 crossref_primary_10_3390_v10100560 crossref_primary_10_1016_j_vaccine_2011_07_093 crossref_primary_10_1016_j_vaccine_2012_02_071 crossref_primary_10_1016_S2589_7500_19_30222_5 crossref_primary_10_1111_j_1750_2659_2011_00230_x crossref_primary_10_1097_MLR_0b013e3182028c1a crossref_primary_10_1038_s41598_018_22307_8 crossref_primary_10_1186_s12879_018_3220_8 crossref_primary_10_1128_JCM_03265_13 crossref_primary_10_1111_1475_679X_12486 crossref_primary_10_1146_annurev_virology_012420_022445 crossref_primary_10_1016_j_vaccine_2011_05_001 crossref_primary_10_1017_S095026881400003X crossref_primary_10_1080_21645515_2019_1678997 crossref_primary_10_1016_j_vaccine_2018_05_057 crossref_primary_10_1186_1471_2458_12_968 crossref_primary_10_3390_v11010006 crossref_primary_10_1016_S0021_9258_17_49923_6 crossref_primary_10_15585_mmwr_rr6601a1 crossref_primary_10_1186_1471_2334_14_40 crossref_primary_10_1093_rheumatology_keaa078 crossref_primary_10_1016_j_cmrp_2015_07_005 crossref_primary_10_4161_hv_23413 crossref_primary_10_1016_S1473_3099_11_70008_1 crossref_primary_10_1097_INF_0000000000001693 crossref_primary_10_1177_0748730411409708 crossref_primary_10_1128_JVI_00605_16 crossref_primary_10_1093_ofid_ofx166 crossref_primary_10_1371_journal_pone_0254319 crossref_primary_10_1080_17513758_2013_801523 crossref_primary_10_1111_j_1469_0691_2012_03914_x crossref_primary_10_1128_JVI_02284_12 crossref_primary_10_1038_mt_2013_284 crossref_primary_10_1371_journal_pone_0169030 crossref_primary_10_1080_21645515_2019_1619406 crossref_primary_10_2196_jmir_2705 crossref_primary_10_1377_hlthaff_2016_0462 crossref_primary_10_55453_rjmm_2022_125_3_8 crossref_primary_10_1007_s00439_019_02108_3 crossref_primary_10_1016_j_coviro_2016_01_016 crossref_primary_10_1080_14737167_2017_1343145 crossref_primary_10_1111_josh_12840 crossref_primary_10_1016_j_tim_2017_09_004 crossref_primary_10_1016_j_jval_2016_05_012 crossref_primary_10_1128_mBio_02091_17 crossref_primary_10_1093_infdis_jiad089 crossref_primary_10_1016_j_vaccine_2011_12_105 crossref_primary_10_1016_j_ajic_2014_08_021 crossref_primary_10_1155_2011_419216 crossref_primary_10_4161_hv_22342 crossref_primary_10_1016_j_vaccine_2010_04_101 crossref_primary_10_1145_3381014 crossref_primary_10_1016_j_jconrel_2018_02_033 crossref_primary_10_1637_8740_032509_ResNote_1 crossref_primary_10_1039_C8BM01443D crossref_primary_10_1093_cid_cix869 crossref_primary_10_1186_1478_7547_10_10 crossref_primary_10_1007_s12325_011_0090_5 crossref_primary_10_3389_fimmu_2018_00600 crossref_primary_10_1080_17476348_2021_1893168 crossref_primary_10_1016_j_amepre_2019_04_007 crossref_primary_10_1186_s13643_023_02319_w crossref_primary_10_1371_journal_pcbi_1007683 crossref_primary_10_1007_s10198_020_01172_1 crossref_primary_10_15406_jlprr_2016_03_00076 crossref_primary_10_1016_j_vaccine_2010_12_078 crossref_primary_10_1155_2013_242970 crossref_primary_10_1089_acm_2011_0706 crossref_primary_10_4161_hv_26715 crossref_primary_10_1093_geroni_igy035 crossref_primary_10_1016_j_amepre_2013_08_021 crossref_primary_10_1097_INF_0b013e31822d70be crossref_primary_10_1128_mBio_01296_19 crossref_primary_10_4161_rna_22343 crossref_primary_10_1016_j_jbi_2010_10_001 crossref_primary_10_1056_NEJMoa1215817 crossref_primary_10_3390_vaccines11010161 crossref_primary_10_1007_s10096_013_1986_6 crossref_primary_10_1016_j_vaccine_2019_12_004 crossref_primary_10_1007_s10865_022_00324_3 crossref_primary_10_1016_j_vaccine_2021_11_011 crossref_primary_10_1371_journal_pone_0069035 crossref_primary_10_3934_mbe_2013_10_1615 crossref_primary_10_3310_hta24670 crossref_primary_10_1186_s12879_016_2175_x crossref_primary_10_1586_14760584_2015_1039520 crossref_primary_10_2105_AJPH_2012_300665 crossref_primary_10_1093_infdis_jiw230 crossref_primary_10_1016_j_vaccine_2012_10_039 crossref_primary_10_1126_sciadv_abm5371 crossref_primary_10_15585_mmwr_rr6505a1 crossref_primary_10_1371_journal_pone_0118934 crossref_primary_10_1017_S095026881700111X crossref_primary_10_1021_acs_jctc_6b00703 crossref_primary_10_1097_INF_0b013e318255e443 crossref_primary_10_1007_s10198_015_0708_7 crossref_primary_10_3389_fimmu_2018_01953 crossref_primary_10_1517_14712598_2011_557658 crossref_primary_10_1016_j_bsheal_2020_04_004 crossref_primary_10_3390_v10100519 crossref_primary_10_1016_j_amepre_2017_11_010 crossref_primary_10_1016_j_eswa_2021_115153 crossref_primary_10_1086_595842 crossref_primary_10_1016_j_coviro_2011_05_005 crossref_primary_10_1586_14760584_2016_1113878 crossref_primary_10_1097_JOM_0000000000000421 crossref_primary_10_1016_j_vaccine_2012_10_025 crossref_primary_10_4161_hv_18561 crossref_primary_10_1093_ofid_ofy214 crossref_primary_10_1021_acsabm_2c00153 crossref_primary_10_1097_INF_0000000000002504 crossref_primary_10_2165_00019053_200826020_00006 crossref_primary_10_3389_fmicb_2018_02596 crossref_primary_10_1016_j_jmb_2022_167460 crossref_primary_10_1017_S0950268818002418 crossref_primary_10_1016_j_amepre_2018_09_013 crossref_primary_10_1016_j_ypmed_2020_106066 crossref_primary_10_1002_btpr_1749 crossref_primary_10_1016_j_mcna_2024_02_003 crossref_primary_10_1165_rcmb_2017_0114TR crossref_primary_10_3390_ijerph17134743 crossref_primary_10_1007_s10588_015_9198_5 crossref_primary_10_1042_CS20160259 crossref_primary_10_1128_jvi_00494_22 crossref_primary_10_1093_ofid_ofad039 crossref_primary_10_1128_JVI_00333_19 crossref_primary_10_1186_s12879_016_1839_x crossref_primary_10_1371_journal_pone_0197246 crossref_primary_10_1007_s40588_016_0041_7 crossref_primary_10_1371_journal_pcbi_1004382 crossref_primary_10_1073_pnas_1108569108 crossref_primary_10_4161_hv_34362 crossref_primary_10_1002_adhm_201500841 crossref_primary_10_1111_j_1749_8198_2010_00343_x crossref_primary_10_4049_jimmunol_2200799 crossref_primary_10_4236_ojrd_2022_121001 crossref_primary_10_1080_10410236_2017_1384353 crossref_primary_10_1016_j_compbiolchem_2018_12_009 crossref_primary_10_3390_vaccines11030557 crossref_primary_10_1016_j_vaccine_2016_02_028 crossref_primary_10_1080_19338244_2015_1058234 crossref_primary_10_1093_cid_ciaa1719 crossref_primary_10_1016_j_ijid_2019_04_023 crossref_primary_10_1007_s10729_014_9310_2 crossref_primary_10_1016_j_vaccine_2017_12_016 crossref_primary_10_1016_j_vaccine_2008_01_040 crossref_primary_10_1016_j_vaccine_2013_11_103 crossref_primary_10_1542_peds_2015_2922 crossref_primary_10_1089_jwh_2011_2876 crossref_primary_10_1186_s12866_015_0507_4 crossref_primary_10_1038_s41598_018_30378_w crossref_primary_10_1016_j_jconrel_2017_11_030 crossref_primary_10_1186_1471_2458_10_724 crossref_primary_10_1016_j_rcsop_2023_100301 crossref_primary_10_3389_fimmu_2021_746447 crossref_primary_10_1002_jmv_24796 crossref_primary_10_1016_j_mayocpiqo_2019_12_005 crossref_primary_10_1016_j_vaccine_2017_12_019 crossref_primary_10_1371_journal_pone_0074863 crossref_primary_10_1021_acs_analchem_7b00769 crossref_primary_10_1080_13658816_2011_556121 crossref_primary_10_1074_jbc_M111_284695 crossref_primary_10_1016_j_jval_2015_03_1794 crossref_primary_10_1097_QCO_0000000000000287 crossref_primary_10_1177_1359105313510338 crossref_primary_10_1016_j_cmi_2018_12_017 crossref_primary_10_1177_1010539512460269 crossref_primary_10_1128_JCM_03113_12 crossref_primary_10_1371_journal_pone_0039423 crossref_primary_10_1002_jmv_25652 crossref_primary_10_2807_1560_7917_ES2015_20_8_21043 crossref_primary_10_1097_JOM_0b013e3182677d34 crossref_primary_10_1016_j_vaccine_2017_12_007 crossref_primary_10_1371_journal_pone_0206837 crossref_primary_10_1016_j_ijheh_2019_01_001 crossref_primary_10_1016_j_jddst_2024_105901 crossref_primary_10_1111_jam_13051 crossref_primary_10_1186_s12879_019_3930_6 crossref_primary_10_1186_s12879_018_3322_3 crossref_primary_10_1186_s40249_015_0077_6 crossref_primary_10_1038_nrmicro2613 crossref_primary_10_9778_cmajo_20160018 crossref_primary_10_1177_2055207620906968 crossref_primary_10_1186_s12889_021_10561_x crossref_primary_10_1093_qje_qjw005 crossref_primary_10_1155_2021_2460553 crossref_primary_10_1038_s41533_020_0165_3 crossref_primary_10_3389_fmicb_2015_00848 crossref_primary_10_1016_j_japh_2016_08_018 crossref_primary_10_1016_j_vaccine_2008_02_063 crossref_primary_10_1371_journal_pone_0169679 crossref_primary_10_1128_JCM_00740_13 crossref_primary_10_1371_journal_pone_0073313 crossref_primary_10_3390_vaccines3020239 crossref_primary_10_1073_pnas_2310677121 crossref_primary_10_1016_j_vaccine_2015_10_056 crossref_primary_10_2146_ajhp080296 crossref_primary_10_1016_j_imu_2021_100809 crossref_primary_10_1016_j_jiph_2019_05_005 crossref_primary_10_2471_BLT_17_199588 crossref_primary_10_3201_eid1708_101270 crossref_primary_10_1099_jgv_0_001015 crossref_primary_10_4049_jimmunol_1400432 crossref_primary_10_1016_j_vaccine_2014_03_097 crossref_primary_10_1080_22221751_2021_1972769 crossref_primary_10_4049_jimmunol_1202790 crossref_primary_10_12688_wellcomeopenres_16842_1 crossref_primary_10_2105_AJPH_2015_302671 crossref_primary_10_1016_j_jval_2011_03_005 crossref_primary_10_1371_journal_pone_0249785 crossref_primary_10_1039_C6LC01074A crossref_primary_10_1007_s10654_023_00966_w crossref_primary_10_3390_vaccines11061089 crossref_primary_10_1016_j_sapharm_2017_02_010 crossref_primary_10_1093_aje_kwu303 crossref_primary_10_1021_acsnano_8b09410 crossref_primary_10_1038_s41598_020_63712_2 crossref_primary_10_3390_v11030229 crossref_primary_10_1371_journal_pone_0282101 crossref_primary_10_1007_s40265_014_0245_1 crossref_primary_10_1128_JVI_01984_18 crossref_primary_10_1016_S2213_2600_15_00278_7 crossref_primary_10_1016_j_vaccine_2020_02_081 crossref_primary_10_1016_j_virol_2020_02_005 crossref_primary_10_1016_j_vaccine_2016_04_057 crossref_primary_10_37901_jcphp19_00004 crossref_primary_10_1007_s41030_021_00169_2 crossref_primary_10_1634_theoncologist_2011_0220 crossref_primary_10_1128_mBio_00085_16 crossref_primary_10_1016_j_epidem_2020_100387 crossref_primary_10_1186_s12879_018_2967_2 crossref_primary_10_1007_s00281_016_0558_0 crossref_primary_10_1007_s12098_017_2420_3 crossref_primary_10_1177_1403494810396401 crossref_primary_10_1017_S0950268818002832 crossref_primary_10_1038_s41598_023_46079_y crossref_primary_10_1128_JVI_00510_10 crossref_primary_10_1080_22221751_2019_1572433 crossref_primary_10_1016_j_smim_2013_04_010 crossref_primary_10_1164_rccm_201412_2245ED crossref_primary_10_1080_21645515_2017_1290018 crossref_primary_10_1089_hum_2013_215 crossref_primary_10_1146_annurev_virology_111821_115447 crossref_primary_10_1586_14760584_7_6_713 crossref_primary_10_1002_ajpa_24517 crossref_primary_10_1111_j_1440_1843_2009_01554_x crossref_primary_10_1016_j_cie_2023_109397 crossref_primary_10_1016_j_vaccine_2024_07_008 crossref_primary_10_1542_peds_2018_2580 crossref_primary_10_1002_14651858_CD011857_pub2 crossref_primary_10_16899_gopctd_379753 crossref_primary_10_4061_2011_298787 crossref_primary_10_1093_ijpp_riac007 crossref_primary_10_1128_JVI_00286_17 crossref_primary_10_3390_v9100269 crossref_primary_10_1128_JVI_00615_15 crossref_primary_10_1371_journal_pcbi_1005201 crossref_primary_10_1128_mBio_00481_17 crossref_primary_10_3389_fimmu_2022_1006998 crossref_primary_10_1371_journal_pone_0157657 crossref_primary_10_1016_j_vaccine_2014_02_084 crossref_primary_10_1016_j_japh_2015_11_008 crossref_primary_10_1016_j_jval_2022_03_011 crossref_primary_10_1002_sim_7196 |
| Cites_doi | 10.1086/338363 10.1023/A:1025598106257 10.1016/j.amepre.2005.05.011 10.3386/w10199 10.1007/s00198-004-1694-2 10.1136/ebm.7.2.63 10.1016/S0264-410X(00)00449-7 10.1001/jama.292.11.1333 10.1016/j.vaccine.2006.09.041 10.1001/jama.289.2.179 10.3201/eid1210.051015 10.1542/peds.107.6.1405 10.1542/peds.2005-0929 10.1001/jama.284.13.1655 10.3310/hta7350 10.2105/AJPH.72.9.1008 10.1016/S0264-410X(97)00003-0 10.1001/jama.284.13.1677 10.1542/peds.113.3.585 10.1016/S0264-410X(01)00471-6 10.1007/BF03405054 10.1016/S0140-6736(05)67884-1 10.2307/3323826 10.1093/infdis/169.1.68 10.1056/NEJM200001273420402 10.1098/rstb.2001.0982 10.1016/S0140-6736(05)67339-4 10.3201/eid0505.990507 |
| ContentType | Journal Article |
| Copyright | Elsevier Ltd 2007 Elsevier Ltd 2007 INIST-CNRS Copyright Elsevier Limited Jun 28, 2007 |
| Copyright_xml | – notice: Elsevier Ltd – notice: 2007 Elsevier Ltd – notice: 2007 INIST-CNRS – notice: Copyright Elsevier Limited Jun 28, 2007 |
| DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QL 7RV 7T2 7T5 7U9 7X7 7XB 88C 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9- K9. KB0 LK8 M0R M0S M0T M1P M2O M7N M7P MBDVC NAPCQ PQEST PQQKQ PQUKI Q9U 7X8 |
| DOI | 10.1016/j.vaccine.2007.03.046 |
| DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) ProQuest Nursing & Allied Health Database Health and Safety Science Abstracts (Full archive) Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Family Health Database (Proquest) Health & Medical Collection (Alumni Edition) ProQuest Health Management Database PML(ProQuest Medical Library) Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Research Library Prep ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE Research Library Prep MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Veterinary Medicine Biology Pharmacy, Therapeutics, & Pharmacology Economics |
| EISSN | 1873-2518 |
| EndPage | 5096 |
| ExternalDocumentID | 3420786461 10_1016_j_vaccine_2007_03_046 17544181 18846567 S0264410X07003854 1_s2_0_S0264410X07003854 |
| Genre | Journal Article |
| GeographicLocations | United States United States--US |
| GeographicLocations_xml | – name: United States – name: United States--US |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 0SF 123 1B1 1P~ 1RT 1~. 1~5 29Q 3V. 4.4 457 4G. 53G 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8P~ 9JM AAAJQ AABNK AACTN AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AAXKI AAXUO ABBQC ABFNM ABFRF ABJNI ABKYH ABMAC ABMZM ABRWV ABUWG ABXDB ACDAQ ACGFO ACGFS ACIUM ACPRK ACRLP ADBBV ADEZE ADFRT ADMUD ADVLN AEBSH AEFWE AEKER AENEX AEVXI AEXOQ AFCTW AFJKZ AFKRA AFKWA AFRAH AFRHN AFTJW AFXIZ AGEKW AGGSO AGHFR AGUBO AGYEJ AHHHB AHMBA AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALIPV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AQUVI ASPBG AVWKF AXJTR AZFZN AZQEC BBNVY BENPR BHPHI BKEYQ BKNYI BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CJTIS CNWQP CS3 DWQXO EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HCIFZ HEJ HLV HMG HMK HMO HVGLF HX~ HZ~ IHE J1W K9- KOM L7B LK8 LUGTX LW9 M0R M0T M1P M29 M2O M41 M7P MO0 N9A NAPCQ O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. PQQKQ PROAC PSQYO Q38 R2- RIG ROL RPZ SAB SAE SCC SDF SDG SDP SES SEW SIN SNL SPCBC SSH SSI SSZ SVS T5K UV1 WH7 WOW WUQ XPP Z5R ZGI ZXP ~G- AAIAV ABLVK ABYKQ AESVU AJBFU EFLBG HMCUK LCYCR QYZTP UKHRP ABPIF ABPTK IQODW CGR CUY CVF ECM EIF NPM AAYXX ACRPL ADNMO CITATION 7QL 7T2 7T5 7U9 7XB 8FK C1K H94 K9. M7N MBDVC PQEST PQUKI Q9U 7X8 |
| ID | FETCH-LOGICAL-c620t-6fd236174e1424c0c814d76507a0a79eb102c810852a846fd59496648c799d3b3 |
| IEDL.DBID | 8C1 |
| ISSN | 0264-410X |
| IngestDate | Wed Dec 04 16:02:48 EST 2024 Wed Dec 04 11:33:54 EST 2024 Tue Nov 19 05:29:38 EST 2024 Fri Dec 06 03:49:39 EST 2024 Sat Sep 28 07:48:00 EDT 2024 Sun Oct 22 16:07:15 EDT 2023 Fri Feb 23 02:32:28 EST 2024 Tue Oct 15 22:55:51 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 27 |
| Keywords | Productivity losses Health-care cost Disease burden Influenza Infection Viral disease |
| Language | English |
| License | CC BY 4.0 https://www.elsevier.com/tdm/userlicense/1.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c620t-6fd236174e1424c0c814d76507a0a79eb102c810852a846fd59496648c799d3b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doi.org/10.1016/j.vaccine.2007.03.046 |
| PMID | 17544181 |
| PQID | 1559084434 |
| PQPubID | 105530 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_70618253 proquest_miscellaneous_20307385 proquest_journals_1559084434 crossref_primary_10_1016_j_vaccine_2007_03_046 pubmed_primary_17544181 pascalfrancis_primary_18846567 elsevier_sciencedirect_doi_10_1016_j_vaccine_2007_03_046 elsevier_clinicalkeyesjournals_1_s2_0_S0264410X07003854 |
| PublicationCentury | 2000 |
| PublicationDate | 2007-06-28 |
| PublicationDateYYYYMMDD | 2007-06-28 |
| PublicationDate_xml | – month: 06 year: 2007 text: 2007-06-28 day: 28 |
| PublicationDecade | 2000 |
| PublicationPlace | Oxford |
| PublicationPlace_xml | – name: Oxford – name: Netherlands – name: Kidlington |
| PublicationTitle | Vaccine |
| PublicationTitleAlternate | Vaccine |
| PublicationYear | 2007 |
| Publisher | Elsevier Ltd Elsevier Elsevier Limited |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier – name: Elsevier Limited |
| References | U.S. Department of Labor BoLS. National compensation survey: occupational wages in the United States, July 2003. Summary 04-03; 2004. Glezen, Simonsen (bib49) 2005; 293 (bib32) 2002 Prosser, O’Brien, Molinari, Hohman, Nichol, Wortley (bib25) 2005 World Health Organization. Manual of the international statistical classification of diseases, injuries, and causes of death, based on recommendations of the Ninth Revision Conference, 1975. Geneva; 1977. Viscusi, Aldy (bib30) 2003; 27 Viscusi (bib36) 1993; 31 Helms, Guerra, Klein, Schaffner, Arvin, Peter (bib53) 2005; 29 Neuzil, Zhu, Griffin, Edwards, Thompson, Tollefson (bib8) 2002; 185 Thompson, Shay, Weintraub, Brammer, Cox, Anderson (bib16) 2003; 289 O’Brien, Uyeki, Shay, Thompson, Kleinman, McAdam (bib21) 2004; 113 Beyer, Palache, de Jong, Osterhaus (bib48) 2002; 20 Thomson Medstat. Marketscan; 2003. Belshe, Gruber (bib46) 2001; 356 Aldy JE, Viscusi WK. Age variations in workers’ value of statistical life. NBER Working Paper Series. Working Paper 10199; 2003. . Mincer (bib39) 1993; vol. I Thompson, Shay, Weintraub, Brammer, Bridges, Cox (bib15) 2004; 292 Strunk, Ginsburg, Gabel (bib44) 2001; 20 (bib33) 1997 National Research Council CotIMfAoRtPH (bib35) 1983 Anderson, Minino, Hoyert, Rosenberg (bib17) 2001; 49 Mendelman, Cordiva, Cho (bib47) 2001; 19 Arias (bib24) 2006; 54 Bridges, Thompson, Meltzer, Reeve, Talamonti, Cox (bib5) 2000; 284 Centers for Disease Control and Prevention (bib1) 2006; 55 Mincer (bib40) 1993; vol. II Mullooly, Barker (bib10) 1982; 72 Turner, Wailoo, Nicholson, Cooper, Sutton, Abrams (bib3) 2003; 7 Centers for Disease Control and Prevention. National health interview survey. National Center for Health Statistics; 2002. Orsini, Rousculp, Long, Wang (bib45) 2005; 16 Viscusi, Magat, Forrest (bib37) 1988; 7 Prosser, Bridges, Uyeki (bib26) 2006; 12 Schwartz (bib4) 2002; 7 Spurr (bib31) 2005 Hurwitz, Haber, Chang, Shope, Teo, Ginsberg (bib22) 2000; 284 Killingsworth (bib38) 1983 Izurieta, Thompson, Kramarz, Shay, Davis, DeStefano (bib14) 2000; 342 (bib54) 2006 Menec, Black, MacWilliam, Aoki (bib23) 2003; 94 Jefferson, Rivetti, Rudin, Di Petrantonj, Demicheli (bib50) 2005; 366 Yogev (bib52) 2005; 116 Meltzer, Cox, Fukuda (bib2) 1999; 5 Keitel, Cate, Couch, Huggins, Hess (bib7) 1997; 15 Haddix, Teutsch, Corso (bib29) 2003 Edwards, Dupont, Westrich, Plummer, Palmer, Wright (bib6) 1994; 169 Moody RJ. Employers pay a steep subsidy for programs. Bus J Portland 7 July, 2005 Brammer, Izurieta, Fukuda, Schmeltz, Regnery, Hall (bib13) 2000; 49 Thompson, Weintraub, Shay, Brammer, Cox, Fukuda (bib18) 2005 Centers for Disease Control and Prevention National Center for Health Statistics (bib9) 1998 Mullooly, Bridges, Thompson, Chen, Weintraub, Jackson (bib19) 2007; 25 National Research Council CoRAoHAP (bib34) 1994 Hall, Owings (bib11) 2002; 329 Skaggs, Clemens, Vitale, Femino, Kay (bib43) 2001; 107 Simonsen, Viboud, Taylor (bib51) 2005; 366 Skaggs (10.1016/j.vaccine.2007.03.046_bib43) 2001; 107 10.1016/j.vaccine.2007.03.046_bib41 10.1016/j.vaccine.2007.03.046_bib42 Belshe (10.1016/j.vaccine.2007.03.046_bib46) 2001; 356 (10.1016/j.vaccine.2007.03.046_bib33) 1997 National Research Council CoRAoHAP (10.1016/j.vaccine.2007.03.046_bib34) 1994 Mincer (10.1016/j.vaccine.2007.03.046_bib39) 1993; vol. I Schwartz (10.1016/j.vaccine.2007.03.046_bib4) 2002; 7 Jefferson (10.1016/j.vaccine.2007.03.046_bib50) 2005; 366 Turner (10.1016/j.vaccine.2007.03.046_bib3) 2003; 7 Hall (10.1016/j.vaccine.2007.03.046_bib11) 2002; 329 Mendelman (10.1016/j.vaccine.2007.03.046_bib47) 2001; 19 Izurieta (10.1016/j.vaccine.2007.03.046_bib14) 2000; 342 Centers for Disease Control and Prevention (10.1016/j.vaccine.2007.03.046_bib1) 2006; 55 Bridges (10.1016/j.vaccine.2007.03.046_bib5) 2000; 284 (10.1016/j.vaccine.2007.03.046_bib54) 2006 Anderson (10.1016/j.vaccine.2007.03.046_bib17) 2001; 49 Menec (10.1016/j.vaccine.2007.03.046_bib23) 2003; 94 Simonsen (10.1016/j.vaccine.2007.03.046_bib51) 2005; 366 Mullooly (10.1016/j.vaccine.2007.03.046_bib19) 2007; 25 Prosser (10.1016/j.vaccine.2007.03.046_bib26) 2006; 12 Hurwitz (10.1016/j.vaccine.2007.03.046_bib22) 2000; 284 Keitel (10.1016/j.vaccine.2007.03.046_bib7) 1997; 15 Viscusi (10.1016/j.vaccine.2007.03.046_bib37) 1988; 7 O’Brien (10.1016/j.vaccine.2007.03.046_bib21) 2004; 113 Thompson (10.1016/j.vaccine.2007.03.046_bib18) 2005 10.1016/j.vaccine.2007.03.046_bib20 Killingsworth (10.1016/j.vaccine.2007.03.046_bib38) 1983 10.1016/j.vaccine.2007.03.046_bib27 Spurr (10.1016/j.vaccine.2007.03.046_bib31) 2005 10.1016/j.vaccine.2007.03.046_bib28 Thompson (10.1016/j.vaccine.2007.03.046_bib16) 2003; 289 Orsini (10.1016/j.vaccine.2007.03.046_bib45) 2005; 16 Mullooly (10.1016/j.vaccine.2007.03.046_bib10) 1982; 72 (10.1016/j.vaccine.2007.03.046_bib32) 2002 Haddix (10.1016/j.vaccine.2007.03.046_bib29) 2003 National Research Council CotIMfAoRtPH (10.1016/j.vaccine.2007.03.046_bib35) 1983 Neuzil (10.1016/j.vaccine.2007.03.046_bib8) 2002; 185 10.1016/j.vaccine.2007.03.046_bib12 Beyer (10.1016/j.vaccine.2007.03.046_bib48) 2002; 20 Mincer (10.1016/j.vaccine.2007.03.046_bib40) 1993; vol. II Thompson (10.1016/j.vaccine.2007.03.046_bib15) 2004; 292 Prosser (10.1016/j.vaccine.2007.03.046_bib25) 2005 Yogev (10.1016/j.vaccine.2007.03.046_bib52) 2005; 116 Viscusi (10.1016/j.vaccine.2007.03.046_bib30) 2003; 27 Arias (10.1016/j.vaccine.2007.03.046_bib24) 2006; 54 Edwards (10.1016/j.vaccine.2007.03.046_bib6) 1994; 169 Helms (10.1016/j.vaccine.2007.03.046_bib53) 2005; 29 Strunk (10.1016/j.vaccine.2007.03.046_bib44) 2001; 20 Centers for Disease Control and Prevention National Center for Health Statistics (10.1016/j.vaccine.2007.03.046_bib9) 1998 Brammer (10.1016/j.vaccine.2007.03.046_bib13) 2000; 49 Viscusi (10.1016/j.vaccine.2007.03.046_bib36) 1993; 31 Meltzer (10.1016/j.vaccine.2007.03.046_bib2) 1999; 5 Glezen (10.1016/j.vaccine.2007.03.046_bib49) 2005; 293 |
| References_xml | – volume: 5 start-page: 659 year: 1999 end-page: 671 ident: bib2 article-title: The economic impact of pandemic influenza in the United States: priorities for intervention publication-title: Emerg Infect Dis contributor: fullname: Fukuda – volume: 366 start-page: 2086 year: 2005 ident: bib51 article-title: Influenza vaccination in elderly people publication-title: Lancet contributor: fullname: Taylor – volume: vol. II year: 1993 ident: bib40 publication-title: Collected essays of Jacob Mincer contributor: fullname: Mincer – volume: 113 start-page: 585 year: 2004 end-page: 589 ident: bib21 article-title: Incidence of outpatient visits and hospitalizations related to influenza in infants and young children publication-title: Pediatrics contributor: fullname: McAdam – volume: 72 start-page: 1008 year: 1982 end-page: 1016 ident: bib10 article-title: Impact of type A influenza on children: a retrospective study publication-title: Am J Pub Health contributor: fullname: Barker – volume: 54 start-page: 1 year: 2006 end-page: 40 ident: bib24 article-title: United states life tables, 2003 publication-title: Natl Vital Stat Rep contributor: fullname: Arias – volume: 366 start-page: 1165 year: 2005 end-page: 1174 ident: bib50 article-title: Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review publication-title: Lancet contributor: fullname: Demicheli – year: 1983 ident: bib35 article-title: Risk assessment in the federal government: managing the process contributor: fullname: National Research Council CotIMfAoRtPH – volume: 7 start-page: 227 year: 1988 end-page: 245 ident: bib37 article-title: Altruistic and private valuations of risk reduction publication-title: J Policy Anal Manage contributor: fullname: Forrest – volume: 342 start-page: 232 year: 2000 end-page: 239 ident: bib14 article-title: Influenza and the rates of hospitalization for respiratory disease among infants and young children publication-title: N Engl J Med contributor: fullname: DeStefano – volume: vol. I year: 1993 ident: bib39 publication-title: Collected essays of Jacob Mincer contributor: fullname: Mincer – volume: 25 start-page: 846 year: 2007 end-page: 855 ident: bib19 article-title: Influenza- and RSV-associated hospitalizations among adults publication-title: Vaccine contributor: fullname: Jackson – volume: 94 start-page: 59 year: 2003 end-page: 63 ident: bib23 article-title: The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality publication-title: Can J Public Health contributor: fullname: Aoki – volume: 20 start-page: 1 year: 2001 end-page: 8 ident: bib44 article-title: Tracking health care costs: growth accelerates again in 2001 publication-title: Health Affairs contributor: fullname: Gabel – volume: 7 start-page: 63 year: 2002 ident: bib4 article-title: An intranasal influenza vaccine for the prevention of influenza in healthy children was cost effective publication-title: Evid Based Med contributor: fullname: Schwartz – volume: 55 start-page: 1 year: 2006 end-page: 42 ident: bib1 article-title: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) publication-title: MMWR contributor: fullname: Centers for Disease Control and Prevention – year: 2003 ident: bib29 article-title: Prevention effectiveness: a guide to decision analysis and economic evaluation contributor: fullname: Corso – volume: 19 start-page: 2221 year: 2001 end-page: 2226 ident: bib47 article-title: Safety, efficacy, and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults publication-title: Vaccine contributor: fullname: Cho – volume: 116 start-page: 1214 year: 2005 end-page: 1215 ident: bib52 article-title: Influenza vaccine confusion: a call for an alternative evidence-based approach publication-title: Pediatrics contributor: fullname: Yogev – year: 2005 ident: bib18 article-title: Health burden of influenza in healthy adults aged 18–49 years publication-title: Panel session presented at the Universal vaccination against influenza—are we ready? contributor: fullname: Fukuda – volume: 292 start-page: 1333 year: 2004 end-page: 1340 ident: bib15 article-title: Influenza-associated hospitalizations in the United States publication-title: JAMA contributor: fullname: Cox – volume: 289 start-page: 179 year: 2003 end-page: 186 ident: bib16 article-title: Mortality associated with influenza and respiratory synctial virus in the United States publication-title: JAMA contributor: fullname: Anderson – volume: 20 start-page: 1340 year: 2002 end-page: 1353 ident: bib48 article-title: Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis publication-title: Vaccine contributor: fullname: Osterhaus – year: 1983 ident: bib38 article-title: Labor supply contributor: fullname: Killingsworth – year: 1998 ident: bib9 article-title: Vital statistics mortality data, multiple cause detail, 1972–1998 contributor: fullname: Centers for Disease Control and Prevention National Center for Health Statistics – volume: 284 start-page: 1677 year: 2000 end-page: 1682 ident: bib22 article-title: Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts publication-title: JAMA contributor: fullname: Ginsberg – volume: 29 start-page: 221 year: 2005 end-page: 226 ident: bib53 article-title: Strengthening the nation's influenza vaccination system: a National Vaccine Advisory Committee assessment publication-title: Am J Prev Med contributor: fullname: Peter – volume: 15 start-page: 1114 year: 1997 end-page: 1122 ident: bib7 article-title: Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period publication-title: Vaccine contributor: fullname: Hess – volume: 49 start-page: 13 year: 2000 end-page: 28 ident: bib13 article-title: Surveillance for influenza—United States, 1994–95, 1995–96, and 1996–97 seasons publication-title: MMWR CDC Surveill Summ contributor: fullname: Hall – volume: 356 start-page: 1947 year: 2001 end-page: 1951 ident: bib46 article-title: Safety, Efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children publication-title: Philos Trans R Soc Lond B Biol Sci contributor: fullname: Gruber – volume: 12 start-page: 1548 year: 2006 end-page: 1558 ident: bib26 article-title: Should we vaccinate more children against influenza? projected health benefits, risks, and cost-effectiveness publication-title: Emerg Infect Dis contributor: fullname: Uyeki – volume: 27 start-page: 5 year: 2003 end-page: 76 ident: bib30 article-title: The value of a statistical life: a critical review of market estimates throughout the world publication-title: J Risk Uncert contributor: fullname: Aldy – volume: 31 start-page: 1912 year: 1993 end-page: 1946 ident: bib36 article-title: The value of risk to life and health publication-title: J Econ Literat contributor: fullname: Viscusi – volume: 7 start-page: 3 year: 2003 end-page: 13 ident: bib3 article-title: Systematic review and economic decision modelling for the prevention and treatment of influenza A and B publication-title: Health Technol Assess contributor: fullname: Abrams – year: 2005 ident: bib25 article-title: Costs and cost-effectiveness of delivering adult influenza vaccination in non-traditional settings publication-title: Panel session presented at the 27th annual meeting of the society for medical decision making contributor: fullname: Wortley – year: 2002 ident: bib32 article-title: @Risk Version 4.5.2 – volume: 293 start-page: 1 year: 2005 end-page: 2 ident: bib49 article-title: Benefits of influenza vaccine in US elderly—new studies raise questions publication-title: Int J Epidemiol contributor: fullname: Simonsen – volume: 107 start-page: 1405 year: 2001 end-page: 1408 ident: bib43 article-title: Access to orthopedic care for children with Medicaid versus private insurance publication-title: Pediatrics contributor: fullname: Kay – year: 2006 ident: bib54 publication-title: National influenza vaccine summit: minutes of meeting – volume: 284 start-page: 1655 year: 2000 end-page: 1663 ident: bib5 article-title: Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial publication-title: JAMA contributor: fullname: Cox – volume: 169 start-page: 68 year: 1994 end-page: 76 ident: bib6 article-title: A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease publication-title: J Infect Dis contributor: fullname: Wright – year: 2005 ident: bib31 article-title: Economic foundations of law contributor: fullname: Spurr – volume: 49 start-page: 1 year: 2001 end-page: 32 ident: bib17 article-title: Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates publication-title: Natl Vital Stat Rep contributor: fullname: Rosenberg – volume: 185 start-page: 147 year: 2002 end-page: 152 ident: bib8 article-title: Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study publication-title: J Infect Dis contributor: fullname: Tollefson – year: 1994 ident: bib34 article-title: Science and judgement in risk assessment contributor: fullname: National Research Council CoRAoHAP – volume: 329 start-page: 1 year: 2002 end-page: 18 ident: bib11 article-title: 2000 National Hospital Discharge Survey publication-title: Adv Data contributor: fullname: Owings – volume: 16 start-page: 359 year: 2005 end-page: 371 ident: bib45 article-title: Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures publication-title: Osteoporos Int contributor: fullname: Wang – year: 1997 ident: bib33 article-title: The presidential/congressional commission on risk assessment and risk management. risk assessment and risk management in regulatory decision-making – volume: 185 start-page: 147 year: 2002 ident: 10.1016/j.vaccine.2007.03.046_bib8 article-title: Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study publication-title: J Infect Dis doi: 10.1086/338363 contributor: fullname: Neuzil – volume: 49 start-page: 1 issue: 2 year: 2001 ident: 10.1016/j.vaccine.2007.03.046_bib17 article-title: Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates publication-title: Natl Vital Stat Rep contributor: fullname: Anderson – volume: 27 start-page: 5 year: 2003 ident: 10.1016/j.vaccine.2007.03.046_bib30 article-title: The value of a statistical life: a critical review of market estimates throughout the world publication-title: J Risk Uncert doi: 10.1023/A:1025598106257 contributor: fullname: Viscusi – volume: 29 start-page: 221 issue: 3 year: 2005 ident: 10.1016/j.vaccine.2007.03.046_bib53 article-title: Strengthening the nation's influenza vaccination system: a National Vaccine Advisory Committee assessment publication-title: Am J Prev Med doi: 10.1016/j.amepre.2005.05.011 contributor: fullname: Helms – ident: 10.1016/j.vaccine.2007.03.046_bib28 doi: 10.3386/w10199 – volume: 16 start-page: 359 issue: 4 year: 2005 ident: 10.1016/j.vaccine.2007.03.046_bib45 article-title: Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures publication-title: Osteoporos Int doi: 10.1007/s00198-004-1694-2 contributor: fullname: Orsini – year: 2006 ident: 10.1016/j.vaccine.2007.03.046_bib54 – volume: 293 start-page: 1 issue: 1 year: 2005 ident: 10.1016/j.vaccine.2007.03.046_bib49 article-title: Benefits of influenza vaccine in US elderly—new studies raise questions publication-title: Int J Epidemiol contributor: fullname: Glezen – year: 1998 ident: 10.1016/j.vaccine.2007.03.046_bib9 contributor: fullname: Centers for Disease Control and Prevention National Center for Health Statistics – year: 1994 ident: 10.1016/j.vaccine.2007.03.046_bib34 contributor: fullname: National Research Council CoRAoHAP – volume: 49 start-page: 13 issue: 3 year: 2000 ident: 10.1016/j.vaccine.2007.03.046_bib13 article-title: Surveillance for influenza—United States, 1994–95, 1995–96, and 1996–97 seasons publication-title: MMWR CDC Surveill Summ contributor: fullname: Brammer – ident: 10.1016/j.vaccine.2007.03.046_bib27 – volume: 7 start-page: 63 issue: 2 year: 2002 ident: 10.1016/j.vaccine.2007.03.046_bib4 article-title: An intranasal influenza vaccine for the prevention of influenza in healthy children was cost effective publication-title: Evid Based Med doi: 10.1136/ebm.7.2.63 contributor: fullname: Schwartz – year: 2005 ident: 10.1016/j.vaccine.2007.03.046_bib31 contributor: fullname: Spurr – volume: 19 start-page: 2221 issue: 17–19 year: 2001 ident: 10.1016/j.vaccine.2007.03.046_bib47 article-title: Safety, efficacy, and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults publication-title: Vaccine doi: 10.1016/S0264-410X(00)00449-7 contributor: fullname: Mendelman – volume: 292 start-page: 1333 year: 2004 ident: 10.1016/j.vaccine.2007.03.046_bib15 article-title: Influenza-associated hospitalizations in the United States publication-title: JAMA doi: 10.1001/jama.292.11.1333 contributor: fullname: Thompson – volume: 25 start-page: 846 year: 2007 ident: 10.1016/j.vaccine.2007.03.046_bib19 article-title: Influenza- and RSV-associated hospitalizations among adults publication-title: Vaccine doi: 10.1016/j.vaccine.2006.09.041 contributor: fullname: Mullooly – volume: 289 start-page: 179 issue: 2 year: 2003 ident: 10.1016/j.vaccine.2007.03.046_bib16 article-title: Mortality associated with influenza and respiratory synctial virus in the United States publication-title: JAMA doi: 10.1001/jama.289.2.179 contributor: fullname: Thompson – volume: 12 start-page: 1548 issue: 10 year: 2006 ident: 10.1016/j.vaccine.2007.03.046_bib26 article-title: Should we vaccinate more children against influenza? projected health benefits, risks, and cost-effectiveness publication-title: Emerg Infect Dis doi: 10.3201/eid1210.051015 contributor: fullname: Prosser – volume: 107 start-page: 1405 year: 2001 ident: 10.1016/j.vaccine.2007.03.046_bib43 article-title: Access to orthopedic care for children with Medicaid versus private insurance publication-title: Pediatrics doi: 10.1542/peds.107.6.1405 contributor: fullname: Skaggs – volume: 116 start-page: 1214 year: 2005 ident: 10.1016/j.vaccine.2007.03.046_bib52 article-title: Influenza vaccine confusion: a call for an alternative evidence-based approach publication-title: Pediatrics doi: 10.1542/peds.2005-0929 contributor: fullname: Yogev – volume: 284 start-page: 1655 issue: 13 year: 2000 ident: 10.1016/j.vaccine.2007.03.046_bib5 article-title: Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial publication-title: JAMA doi: 10.1001/jama.284.13.1655 contributor: fullname: Bridges – volume: 7 start-page: 3 issue: 35 year: 2003 ident: 10.1016/j.vaccine.2007.03.046_bib3 article-title: Systematic review and economic decision modelling for the prevention and treatment of influenza A and B publication-title: Health Technol Assess doi: 10.3310/hta7350 contributor: fullname: Turner – volume: 72 start-page: 1008 issue: 9 year: 1982 ident: 10.1016/j.vaccine.2007.03.046_bib10 article-title: Impact of type A influenza on children: a retrospective study publication-title: Am J Pub Health doi: 10.2105/AJPH.72.9.1008 contributor: fullname: Mullooly – year: 1983 ident: 10.1016/j.vaccine.2007.03.046_bib35 contributor: fullname: National Research Council CotIMfAoRtPH – ident: 10.1016/j.vaccine.2007.03.046_bib20 – volume: 31 start-page: 1912 issue: 4 year: 1993 ident: 10.1016/j.vaccine.2007.03.046_bib36 article-title: The value of risk to life and health publication-title: J Econ Literat contributor: fullname: Viscusi – year: 2005 ident: 10.1016/j.vaccine.2007.03.046_bib18 article-title: Health burden of influenza in healthy adults aged 18–49 years contributor: fullname: Thompson – ident: 10.1016/j.vaccine.2007.03.046_bib41 – volume: 55 start-page: 1 issue: RR10 year: 2006 ident: 10.1016/j.vaccine.2007.03.046_bib1 article-title: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) publication-title: MMWR contributor: fullname: Centers for Disease Control and Prevention – volume: vol. II year: 1993 ident: 10.1016/j.vaccine.2007.03.046_bib40 contributor: fullname: Mincer – year: 1983 ident: 10.1016/j.vaccine.2007.03.046_bib38 contributor: fullname: Killingsworth – year: 2003 ident: 10.1016/j.vaccine.2007.03.046_bib29 contributor: fullname: Haddix – volume: 20 start-page: 1 issue: 6 year: 2001 ident: 10.1016/j.vaccine.2007.03.046_bib44 article-title: Tracking health care costs: growth accelerates again in 2001 publication-title: Health Affairs contributor: fullname: Strunk – volume: 54 start-page: 1 issue: 14 year: 2006 ident: 10.1016/j.vaccine.2007.03.046_bib24 article-title: United states life tables, 2003 publication-title: Natl Vital Stat Rep contributor: fullname: Arias – volume: 329 start-page: 1 year: 2002 ident: 10.1016/j.vaccine.2007.03.046_bib11 article-title: 2000 National Hospital Discharge Survey publication-title: Adv Data contributor: fullname: Hall – volume: 15 start-page: 1114 issue: 10 year: 1997 ident: 10.1016/j.vaccine.2007.03.046_bib7 article-title: Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period publication-title: Vaccine doi: 10.1016/S0264-410X(97)00003-0 contributor: fullname: Keitel – ident: 10.1016/j.vaccine.2007.03.046_bib42 – year: 1997 ident: 10.1016/j.vaccine.2007.03.046_bib33 – volume: vol. I year: 1993 ident: 10.1016/j.vaccine.2007.03.046_bib39 contributor: fullname: Mincer – volume: 284 start-page: 1677 issue: 13 year: 2000 ident: 10.1016/j.vaccine.2007.03.046_bib22 article-title: Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts publication-title: JAMA doi: 10.1001/jama.284.13.1677 contributor: fullname: Hurwitz – ident: 10.1016/j.vaccine.2007.03.046_bib12 – volume: 113 start-page: 585 issue: 3 year: 2004 ident: 10.1016/j.vaccine.2007.03.046_bib21 article-title: Incidence of outpatient visits and hospitalizations related to influenza in infants and young children publication-title: Pediatrics doi: 10.1542/peds.113.3.585 contributor: fullname: O’Brien – volume: 20 start-page: 1340 issue: 9/10 year: 2002 ident: 10.1016/j.vaccine.2007.03.046_bib48 article-title: Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis publication-title: Vaccine doi: 10.1016/S0264-410X(01)00471-6 contributor: fullname: Beyer – volume: 94 start-page: 59 issue: 1 year: 2003 ident: 10.1016/j.vaccine.2007.03.046_bib23 article-title: The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality publication-title: Can J Public Health doi: 10.1007/BF03405054 contributor: fullname: Menec – volume: 366 start-page: 2086 year: 2005 ident: 10.1016/j.vaccine.2007.03.046_bib51 article-title: Influenza vaccination in elderly people publication-title: Lancet doi: 10.1016/S0140-6736(05)67884-1 contributor: fullname: Simonsen – year: 2005 ident: 10.1016/j.vaccine.2007.03.046_bib25 article-title: Costs and cost-effectiveness of delivering adult influenza vaccination in non-traditional settings contributor: fullname: Prosser – year: 2002 ident: 10.1016/j.vaccine.2007.03.046_bib32 – volume: 7 start-page: 227 issue: 2 year: 1988 ident: 10.1016/j.vaccine.2007.03.046_bib37 article-title: Altruistic and private valuations of risk reduction publication-title: J Policy Anal Manage doi: 10.2307/3323826 contributor: fullname: Viscusi – volume: 169 start-page: 68 year: 1994 ident: 10.1016/j.vaccine.2007.03.046_bib6 article-title: A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease publication-title: J Infect Dis doi: 10.1093/infdis/169.1.68 contributor: fullname: Edwards – volume: 342 start-page: 232 issue: 4 year: 2000 ident: 10.1016/j.vaccine.2007.03.046_bib14 article-title: Influenza and the rates of hospitalization for respiratory disease among infants and young children publication-title: N Engl J Med doi: 10.1056/NEJM200001273420402 contributor: fullname: Izurieta – volume: 356 start-page: 1947 issue: 1416 year: 2001 ident: 10.1016/j.vaccine.2007.03.046_bib46 article-title: Safety, Efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children publication-title: Philos Trans R Soc Lond B Biol Sci doi: 10.1098/rstb.2001.0982 contributor: fullname: Belshe – volume: 366 start-page: 1165 year: 2005 ident: 10.1016/j.vaccine.2007.03.046_bib50 article-title: Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review publication-title: Lancet doi: 10.1016/S0140-6736(05)67339-4 contributor: fullname: Jefferson – volume: 5 start-page: 659 issue: 5 year: 1999 ident: 10.1016/j.vaccine.2007.03.046_bib2 article-title: The economic impact of pandemic influenza in the United States: priorities for intervention publication-title: Emerg Infect Dis doi: 10.3201/eid0505.990507 contributor: fullname: Meltzer |
| SSID | ssj0005319 |
| Score | 2.538279 |
| Snippet | Abstract Background Despite preventive efforts, influenza epidemics are responsible for substantial morbidity and mortality every year in the United States... Despite preventive efforts, influenza epidemics are responsible for substantial morbidity and mortality every year in the United States (US). Vaccination... Background Despite preventive efforts, influenza epidemics are responsible for substantial morbidity and mortality every year in the United States (US).... BACKGROUNDDespite preventive efforts, influenza epidemics are responsible for substantial morbidity and mortality every year in the United States (US).... |
| SourceID | proquest crossref pubmed pascalfrancis elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 5086 |
| SubjectTerms | Adolescent Adult Age Aged Algorithms Allergy and Immunology Applied microbiology Biological and medical sciences Child Child, Preschool Confidence intervals Cost of Illness Costs Costs and Cost Analysis Disease burden Economics Efficiency Epidemics Estimates Female Fundamental and applied biological sciences. Psychology Health care expenditures Health-care cost Hospitalization Hospitalization - economics Humans Illnesses Immunization Infant Infections Influenza Influenza, Human - economics Influenza, Human - epidemiology Influenza, Human - mortality Male Microbiology Middle Aged Monte Carlo Method Morbidity Mortality Pandemics Pneumonia Population Probability Productivity losses Regression Analysis Risk Sick Leave - economics Studies Treatment Outcome United States - epidemiology Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Value of Life |
| SummonAdditionalLinks | – databaseName: Elsevier Medicine Collection dbid: AIKHN link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED-6lo1BGVv2UXddp4fRpzpRbMmW91bKSrbRUmgz8iZkyYb0IQlzWmj_-t5Zck3ZymBvwfFZsu9095PuC-BLIh1VNXFxkhW4QSlwu6Oquo5LK7lFgC5lTQf6p2fZZCp-zORsA467XBgKqwy63-v0VluHK6PwNUer-Xx0wVtbzmcotOTeEs9gC80R-Wq3jr7_nJz1kR5p29-D7o-JoE_kGV0Nb4wlD3YoZpgOOUHhv5uo7ZVp8MPVvuPF05C0NU0nr-FVwJTsyE_7DWxUiwE8910mbwfw4jT4zwdwcO4rVd8esss-8ao5ZAfsvK9hjTSDXxQm0-bqso78LUyRiPkqpsynV7JlzeiYkfA8m_uGJ3cGfzEElmx68RWp6RASDSQLviBWtpkT-BzH7LJZN-9gevLt8ngSh74Msc0Svo6z2lHJllxUlCZnkadj4XKEernhJi9Q-_MEryGYSwzCm9rJQuCuSiibF4VLy_Q9bC6Wi2oHmLTKZEY6a7JSmHFZlspZVaZpVfAMwWAEw44VeuXLb-guLu1KB95RK81c81Qj7yLIO4bpLrcUtWHVhKXZ6LFuEs31H-ITgXqgfCSBGo3LvwbdfyQa_VSVonp0eQR7nazofiKS-s0LkeLQnx_-xtVNLhuzqJbXDQ5COljJp-_IEZDhLj-N4IOXwX5wqm2IAG73_1_sI7zs4iMTtQeb69_X1ScEYetyPyyye_c4LdQ priority: 102 providerName: Elsevier |
| Title | The annual impact of seasonal influenza in the US: Measuring disease burden and costs |
| URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X07003854 https://dx.doi.org/10.1016/j.vaccine.2007.03.046 https://www.ncbi.nlm.nih.gov/pubmed/17544181 https://www.proquest.com/docview/1559084434 https://search.proquest.com/docview/20307385 https://search.proquest.com/docview/70618253 |
| Volume | 25 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwED-xTXxICEEYEBjFD2hPS-ckTuzwgsa0qYBWVWxFfbMcJ5HYQ1NIhzQe-Nu5S5wGJAYvbdX06ihn3_3uG-B1lBTU1aQIojRDAyVDc0eVVRXkNuEWAXqSVOTQP5umk7n4sEgWzuHWuLTKXia2grqoLfnIDyl8xpUQsXi7-hrQ1CiKrroRGluwE5Kio0rx499SPOJ2sAeaGSIQIV8MFTyHl-PvxlLo2nUxjMecMPDfddP9lWnwiVXdqIubsWirk04fwgMHJtlRx_1HcKtcenC7Gy957cHdvuq48eDOmQuie7A_69pVXx-wi6H6qjlg-2w2NLJGeu8z5cq0BbusJ38McyRiXStT1tVYsrpi5GskUM--dFNPfhj8xBBdsvn5G6QmTyRqSeYCQixvyyfwfwpm62bd7ML89OTieBK44QyBTSO-DtKqoL4tUpRUK2eRsaEoJOI9abiRGaoAHuF3iOgigxinKpJMoGkllJVZVsR5_AS2l_WyfAYsscqkJimsSXNhwjzPVWFVHsdlxlNEhD6Me7boVdeDQ_fJaZfa8ZHmaUrNY4189EH2zNN9gSmKxLJx57PRoW4izfU5b_EgX6DgoxCp8EFtKB0E6aCFRg3zv0VHf2yT4VaVoqZ00oe9ft_o4UY229qHV5vLeMQpbmOWZX3V4CIkiFVy8y8kojI09WMfnnb7cVicGhwiinv-78VfwL0-ETJSe7C9_nZVvkS0tc5HsDX-GeKrXMhRe7xGsHP0_uNkiu_vTqazT78A3jQq6w |
| link.rule.ids | 314,780,784,4502,12056,12223,21388,24116,27924,27925,31719,31720,33266,33267,33744,33745,43310,43579,43805,45585,45679,73745,74014,74302 |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwED9BJxgSQhC-AmPzA9rT0rmJkzi8IECbCqxVxVrUN8uxE4k9NN3SIY2_nrvEaYTE4K1qe3XUs-9-vo_fAbwNY0usJjYIkwwvKBled2RRlkFuYm4QoMdxSQH9yTQZL8SXZbx0AbfalVV2NrEx1LYyFCM_pvQZl0JE4v36MqCpUZRddSM07sIOMafHA9j5eDKdfeuLPKJmtAdeNEQgRnzZ9_AcXwx_akPJa8djGA05oeC_e6eHa13jf1a2wy5uR6ONVzp9DI8cnGQfWv0_gTvFyoN77YDJGw92u77j2oP7E5dG9-Bw1hJW3xyxed9_VR-xQzbrqaxR3vtO1TJNyy7rxJ_CAoVYS2bK2i5LVpWMoo0E69mPdu7JL42vGOJLtjh_h9IUi0Q_yVxKiOVNAwX-jmWmqjf1M1icnsw_jQM3niEwScg3QVJaYm5JRUHdcgZVOxI2RcSXaq7TDJ0AD_E9xHShRpRT2jgTeLkS0qRZZqM8eg6DVbUqXgKLjdSJjq3RSS70KM9zaY3Mo6jIeIKY0Idhpxa1blk4VFeedqGcHmmiZqp4pFCPPqSd8lTXYopGsajdCa3VSNWh4uqcN4iQL9H0UZJU-CC3kg6EtOBCoY_536L7f2yT_lGlJFq61Ie9bt-o_kG2G9uHg-3HeMgpc6NXRXVd4yJkimV8-zdSxGV42Y98eNHux35xojhEHPfq34sfwO54PjlTZ5-nX1_Dg64sMpR7MNhcXRdvEHtt8n13wH4D1RwqbA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwED9BJwYSQlC-AmPzA9rT0rqJkzi8ID5WjY9VFVtR3yzHSST20BTcIY2_nrvYaYTE4C1qerXVO9_9zvcF8DJKSupqUoZRmqODkqO7I6u6DguTcIMAPUlqutA_naUnC_FxmSx9_pP1aZWdTmwVddkYuiMfU_iMSyFiMa59WsT8_fT1-ntIE6Qo0urHadyEHbSKPBrAztvj2fxLn_ARt2M-0OkQoZjwZV_PM74Y_dSGAtm-p2E84oSI_26p7q61xf-vdoMvrkemrYWa3od7HlqyN04WHsCNajWEW27Y5NUQbnc1yHYIu6c-pD6Ew7lrXn11xM77Wix7xA7ZvG9rjfTDr5Q505bvso78ISyQiLnGpsxVXLKmZnTzSBCffXMzUH5pfGKINdni7BVS070k2kzmw0OsaIsp8HdKZhq7sY9gMT0-f3cS-lENoUkjvgnTuqQuLpmoqHLOIJsnoswQ_WWa6yxHg8Aj_AzxXaQR8dRlkgt0tIQ0WZ6XcRE_hsGqWVVPgSVG6lQnpdFpIfSkKApZGlnEcZXzFPFhAKOOLWrtOnKoLlXtQnk-0nTNTPFYIR8DyDrmqa7cFBVkZf1ptWqibKS4OuMtOuRLVIMUMBUByC2lByQOaCi0N_9bdP8PMem3KiW1qMsC2OvkRvUb2Qp5AAfb13jgKYqjV1VzaXERUssyuf4bGWI0dPzjAJ44eewXp3aHiOme_XvxA9jFs6U-f5h9eg53ugzJSO7BYPPjsnqBMGxT7Pvz9Rv2Ci6Z |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+annual+impact+of+seasonal+influenza+in+the+US%3A+measuring+disease+burden+and+costs&rft.jtitle=Vaccine&rft.au=Molinari%2C+Noelle-Angelique+M&rft.au=Ortega-Sanchez%2C+Ismael+R&rft.au=Messonnier%2C+Mark+L&rft.au=Thompson%2C+William+W&rft.date=2007-06-28&rft.issn=0264-410X&rft.volume=25&rft.issue=27&rft.spage=5086&rft_id=info:doi/10.1016%2Fj.vaccine.2007.03.046&rft_id=info%3Apmid%2F17544181&rft.externalDocID=17544181 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X07X04237%2Fcov150h.gif |